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Abstract 
Background:  An increased national and local prevalence of heart failure fostered a 
review of the evidence to identify best practice interventions focusing on improving self-care and 
knowledge.  Heart failure remains a leading cause of 30-day readmission in the United States and 
in Madisonville, Kentucky, the site of study.  A review of the literature emphasized improving 
transitions from hospital to home with a multi-dimensional approach.  Self-care and knowledge 
were identified as major determinants to adequately prepare a patient to manage this chronic 
disease.  A pre- and post quasi experimental study was performed at a rural hospital in Kentucky.  
Objective: The goal of this study was to assess changes in knowledge and self-efficacy in heart 
failure with a focus on 30-day readmission rates.  Methods: The Atlanta Heart Failure 
Knowledge Test (AHFKT) and the Self-Care of Heart Failure Index (SCHFI) were measured at 
baseline, 30-day, and 60-day in relation to an American Heart Association telephone follow up.  
Results: The study lasted 160-days.  The sample included 15 patients presenting to the Baptist 
Health Madisonville heart failure clinic that completed all requirements of the study.  A p-value 
of less than 0.05 was used to quantify if data was statistically significant.  The results revealed a 
significant increase in knowledge (F=15.6; p<.001), self-efficacy maintenance (F=10.7; 
P=0.002), and self-efficacy confidence (F=10.8; P= 0.002).  Self-efficacy management was 
found to be increased but not found to be statistically different.  The study resulted in three out of 
15 patients to be readmitted within 30 days.  Also, five out of 15 (33.3%) patients required a 
preventative diuretic.  The patients who received an extra diuretic had a decreased a 60 % 
decreased risk of readmission.  Self-care teaching should emphasize edema monitoring because 
all the readmitted patients in the study were positive for edema at one or more of the time points.  
Furthermore, the change in weight over time was only marginally increased (F=3.6; p=.057).  
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This is thought to be related to recent diuresis during inpatient hospitalization.  Conclusions:  
This study reinforces heart failure clinic transitioning plus an added telephone follow-up 
intervention.  However, it is hard to separate the two components because the in-office education 
and the telephone interventions were not measured separately.  The results of this study suggest 
incorporating the validated AHFKT and SCHFI tools into current heart failure clinic education.  
To enhance this research, future studies regarding health literacy, remote monitoring, and/or a 
flexible diuretic scale are recommended in a larger sample size. 
Keywords: self-efficacy, knowledge, heart failure, education, transition, readmission, follow-up 
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Introduction 
This is a report of the project “The Effect of an American Heart Association Telephone 
Follow-Up Intervention on Knowledge and Self-Efficacy in Rural Heart Failure Patients.” The 
vision of this study was to defend against heart failure disparities by becoming shared partners in 
care.  This project added a telephone intervention to the current evidence driven education 
performed at a heart failure clinic in Madisonville, Kentucky.  The key outcomes assess the 
impact of a multi-component transition on self- efficacy and knowledge.  Additionally, the 
project assessed the intervention impact on readmission and diuretic preventative therapy used 
for reducing emergency exacerbations. 
Background and Significance 
Overview and Statistics 
The United States is estimated to have over 5.1 million heart failure cases with over half a 
million newly diagnosed cases annually (Yancy et al., 2013).  This disease is burdening millions 
and costing our nation over $30 billion each year in treatment, services, and missed work days 
(Centers for Disease Control and Prevention [CDC], 2016).  Kentucky is in the top ten highest 
ranking states of heart failure related deaths [HFRD] (CDC, 2017).  The same source reports 209 
per 100,000 Kentuckians died of heart failure between 2012 and 2014.  Hopkins County, the site 
of study, was found to have approximately 143 HFRD per 100,000 from 2013 to 2015 (CDC, 
2017).   
The American Heart Association (AHA) supports a multi-component approach, along 
with patient compliance, to reduce readmission and mortality risk in patients with heart failure 
(2013).  If patients are not invested in their healthcare it can contribute to poor compliance, 
management, and disease outcomes (Wang, Lin, Lee, & Wu, 2011).   
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Therefore, it is crucial to utilize evidenced based interventions to transition heart failure patients 
into managing this chronic disease.   
Review of the Literature 
Search Description 
 The search began with viewing guidelines from the American Heart Association.  
Level I and II research of systematic reviews, meta-analysis, and random controlled trials 
were used for this synthesis.  Search strategy: keywords and MESH.  Databases used 
were the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and 
PubMed.  Data was restricted in CINAHL from January 2012 to July 2016 and PubMed 
to the last five years.  Search restrictions included peer reviewed, human, and English 
language articles.  Limits set for the search included research article and full text.  Journal 
types were restricted to meta-analysis, systematic review, and randomized controlled 
trial.  The inclusion criteria were specific to the research question to target adults.  The all 
adult’s category is broadly defined by the CINAHL database as adults 18 years and older 
to 80 years and above.  The articles that met the inclusion criteria were evaluated in an 
evaluation and synthesis table (Appendix B).  
 Search Results 
The CINAHL search was categorized into I. and II.  The PubMed search was 
categorized as I, II, and III. The following searches had no exclusions.  The complete 
search strategy is attached (Appendix A). 
Pertinent Findings 
Thirteen articles met the inclusion criteria for this review.  
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 The articles included concepts pertinent to programs or interventions to improve 
outcomes in heart failure after discharge.  The focus of the articles ranged from 
researching interventions for inpatient and outpatient education, home visits, telephone 
calls, and nurse led education to various interventions in classroom, phone, exercise, and 
multi-disciplinary programs.  Four major themes appeared about the use of interventions 
and their effects on heart failure transition: self-efficacy, management, quality of life, and 
outcomes.  These themes reflect the importance of a care plan that is standardized to the 
fundamentals of heart failure management yet individualized per patient need.  
 Broadly, the studies all supported the need for improving the transition home for heart 
failure patients and how this transition process impacts outcomes.  The included studies 
examined various dependent variables, including mortality, quality of life, self-efficacy 
and/or self-care behaviors, care dependency, all cause and heart failure specific 
readmissions, symptoms, six meters walk test, salt and fluid monitoring, medication 
management, and disease knowledge. 
Synthesis 
  All 13 articles broadly reinforce the importance of self-efficacy in heart failure 
outcomes.  Self-efficacy will be inclusive with the following terms: self-care behaviors, 
self-management, and empowerment.  Overall, individual interventions are not 
significant and require multiple components to improve transition outcomes (Wakefield 
et al., 2013) such as readmission, quality of life, knowledge, and mortality. 
Transitions of Care 
There is a higher risk for mortality directly after discharge, which is associated with 
frequency and duration of hospitalization (Bui et al., 2011).   
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Hence, the discharge to home is a vital time to engage patients in self-care to reduce readmission 
risk.  There has been a decrease in readmission rates in response to national efforts to improve 
inpatient to home transitioning (Bergethon, et al., 2016).  The transition efforts use 
multidisciplinary education in the inpatient or outpatient setting.  These interventions included 
nurse led education, home visits, and telephone calls (Fetner et al., 2014); Koberich, Lohrmann, 
Mittag, & Dassen, 2015; Lofvenmark, Saboonchi, Edner, Billing, & Mattiasson, 2013; Powers, 
Cox, Young, Howell, & DiSalvo, 2014; Wakefield et al., 2013; Wang et al., 2011). The 
transition of care includes more than just provider continued care; it involves a relationship 
between knowledge and patient engagement.   
Self-Efficacy and Knowledge 
 Disparities in education or interventional programs targeting self-efficacy are higher in 
rural areas (Dracup et al., 2014).  In Hopkins County, the focus group discussion identified a 
need to improve maintaining patient engagement after the first discharge appointment.  The 
relevance of improving knowledge and self-efficacy is supported by a prevailing amount of 
evidence using multi-component patient education (Appendix B).   
Gaps 
  A barrier in facilitating this change is the evidence did not provide one specific 
intervention (Lofvenmark et al., 2013).  The implications from this review support use of a 
multi-disciplinary approach.  Future research should focus on identifying which interventions 
have the greatest impact; this is the basis for this research study.   
The study was based upon the Stetler Model of Evidence Based Practice framework: 
preparation, validation, decision making, translation, application, and evaluation.  
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 The model uses steps to find and synthesize the research to promote a safe, effective, and 
evidence based recommendation or practice change (Melnyk & Fineout-Overholt, 2015).   
The research evaluates a two-part intervention to improve the expected outcomes of self-efficacy 
and heart failure specific management.  Figure 1 displays a concept model representing the 
Effective Heart Failure Transition. 
Next steps 
  The evidence from this review suggests a need for further research into application of an 
added intervention. The Heart Failure Transition Model individualizes self-care education to 
improve quality of life and mortality.  The management component focuses on improving 
knowledge, symptom recognition, follow-up, and heart failure specific behaviors.  The support 
component preventatively focuses on quality of life and emotional well-being.  This is a broad 
model to use until further research identifies the most beneficial added intervention.  In 
conclusion, evidence supports using multiple patient-specific interventions to improve heart 
failure transition. 
Study Objectives 
The key objectives of this study are to: 
A. Assess changes in knowledge (Appendix D) and self-efficacy (Appendix E) in 
patients with heart failure with a telephone follow up intervention (Appendix C) 
within seven days of the initial office visit.  This knowledge and self-efficacy test will 
be repeated at 30-days and 60-days with a telephone call or in person at follow up 
visits. 
B.   Assess 30-day readmission rates, changes in weight, heart failure stage, 
classification, and in-office preventative diuretic use. 
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Methods 
Study Design 
The study design was a quasi-experimental prospective study with a pre-intervention and 
post-intervention test.  This study did not use randomization control groups.  The study compared 
the following pre-and post-implementation measures: 1) Knowledge (Atlanta Heart Failure 
Knowledge Test) and self-efficacy (Self-Care of Heart Failure Index) in heart failure from pre-
intervention to 30-day and 60-day time points with an American Heart Association telephone 
intervention at seven days after initial visit and 2) 30-day readmission rate and in-office 
preventative diuretic use.  This intervention was conducted for 160 days on 15 newly diagnosed 
heart failure patients.  
Subject Identification 
The sampling process utilized convenience sampling.  This type of sampling was feasible 
for a rural area due to the limited amount of newly diagnosed heart failure patients in the 160-
day time frame.  The time frame occurred September 10, 2017 to February 17, 2018.  The 
inclusion criteria: 1) 18 years and older, all ethnicities, races, cultures and 2) males and females 
newly diagnosed with heart failure stages B-D at Baptist Health Madisonville 3) referred to 
Baptist Heart Failure Clinic.  Exclusion criteria were: 1) patients who were not newly diagnosed 
with heart failure or not referred to clinic 2) younger than 18 years old, and 3) patients without 
the capacity to consent or understand English.  This is a rural community that provides care to 
many surrounding counties in the area.  The patients included all ages, but most of the patient 
population is older than 40 years of age.  This rural area sees predominantly Caucasian and 
African American patients.  However, all ethnicities and ages 18 and above were included.  
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Subject Recruitment 
The following heart failure clinic providers were recruited: Dr. Steven Heatherly, Brenda 
Stephens, APRN, and Brandi Scott, APRN.  The patient population was recruited from newly 
diagnosed heart failure patients.  Recruitment started at the time of inpatient consult or first 
follow-up appointment.  The focus during the first discharge appointment provided education on 
newly diagnosed heart failure management, including: disease process, symptoms, emergency 
identification, diet, weight monitoring, exercise, medications, and smoking cessation.  Patient 
consent was obtained, then a baseline self-efficacy and knowledge score was conducted prior to 
the above described education.  
Subject Compensation/Costs 
Patients did not receive any rewards or payment for taking part in the study.  The 
participation in this study was for educational purposes and did not impact the quality of care 
received if the patient chose to not participate.  There were no costs to the subjects except their 
time to answer questions.  See the attached Informed Consent Appendix F. 
Subject Competency 
The patient or designated family member was deemed competent if alert and oriented and 
able to participate in informed consent. 
Procedures  
Baseline Self-Efficacy and Knowledge  
A knowledge scale (Atlanta Heart Failure Knowledge Test, Appendix D) and a self-
efficacy scale (Self-Care of Heart Failure Index, Appendix E) were given to patients prior to 
their first in-office discussion.  Next, the APRN continued with the standard initial education.  
The knowledge and self-efficacy tests were repeated at 30 and 60 days. 
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The variables assessed throughout the study are 30-day readmission and the use of a preventative 
diuretic during the 60-day study.  Additional variables in the two-month analysis included 
weight, edema, American College of Cardiology/American Heart Association stage and New 
York Heart Association classification.  The 160-day study took place from September 10, 2017 
to February 17, 2018 with the last 60-day post-test potentially being April 18, 2018.  
American Heart Association Telephone Intervention Tool 
The primary investigator contacted the patient or designated family member over the 
telephone within seven days of the first office visit.   
The intervention was completed with an American Heart Association follow up form.  Patient 
education was reinforced based upon the validated American Heart Association tool (Appendix 
C).  
Measures 
 sample characteristics.  
 Demographics were obtained from chart auditing and patient response.  
 knowledge. 
  The AHFKT is scored as 1 point per 28 questions to calculate the overall score.  Zero 
points were given to skipped or incorrect questions.  Scores ranged from 0-28 and were 
converted to a standardized scale of 0 to 100 % (Reilly et al., 2009).  Reilly et al. (2009) asserts 
that a key difference in the AHFKT from other knowledge tests is its nominal right or wrong 
measuring versus the Likert scale.  
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 self-efficacy. 
  To ensure increased efficacy and usability the SCHFI scale is scored in three main 
sections individually instead of an overall score.  The three sections include: 1). Maintenance 2).  
Management 3).  Confidence.  The scores range from 0 to 100 points in each section. 
 maintenance. 
  A reverse coding was performed and raw scores possible for this section ranged from 10 
(lowest) to 40 (highest).  The formula = (sum of section A items -10) * 3.333 (Reigel et al., 
2009). 
 management. 
  The management part of the SCHFI tool was completed only if the patient stated “yes” 
to having trouble breathing or ankle swelling in the past month.  If the patient answers “yes” then 
the scored questions are completed.  If the patient states “no” then you do not proceed with 
asking the questions in this section.  The highest possible score is 24 and the lowest is 4.  The 
formula = (sum of section B items- 4) * 5.  It is appropriate to score skipped questions as the 
lowest possible score.  However, half of the possible remedy questions should be answered to 
adequately address management behaviors (Reigel et al., 2009). 
confidence. 
Confidence scores range from 6 (lowest) to 24 (highest).  The formula = (sum of section 
C items-6) * 5.56.  An adequate measurement is ensured with half of the questions answered in 
this section (Reigel et al. 2009).   
readmission. 
 Acute care hospitals assess the time of readmission between discharge and 30 days for 
reimbursement incentives (Centers for Medicare & Medicaid Services, 2017).  
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preventative diuretic. 
This measurement is inclusive of a diuretic given in-office or a verbal order to a patient to 
take an additional diuretic. 
weight. 
Data collection for weight was assessed at baseline, 30 days, and 60 days.  A combination 
of chart auditing and patient report was used to gather information.  Patients were asked if they 
had a scale to weight at home.  If the patient did not have a scale they were given one.  
 edema.   
A chart audit provided baseline edema (nominal).  However, the 30-day and 60-day 
assessments were provided per patient report on the telephone.  Edema measurement was 
changed to a nominal measurement due to patient reporting may be inaccurate with a graded 
level of edema scale.  Edema was inclusive of extremity edema and abdominal distention.  
Statistical Analysis 
Study variables were summarized using means and standard deviations (continuous 
variables) or frequency distributions (categorical variables).   
Changes in continuous variables of self-efficacy and knowledge were accomplished using 
repeated measures one-way analysis of variance (ANOVA) at baseline, 30-day, and 60-day 
intervals.  A repeated measures ANOVA test was used to measure the three-time points in edema 
and weight.  Thirty-day readmission rate, preventative diuretic, weight, edema, NYHA class, 
AHA stage, income, gender, smoking status, age, and race are assessed with frequencies and 
percentages. 
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The statistical analysis was continued with a significant repeated measures ANOVA model and 
the post-hoc analysis was performed using Fisher’s least significant differences (LSD) method.  
All data analysis was conducted using SPSS, version 24 with an alpha of .05.  
Results 
Descriptive and Statistical Analysis 
sample characteristics. 
A total of 15 patients completed the study out of 20 potential participants.  The attrition 
rate was 25%.  The mean age of study participants was 67.6 years (Table 1).  All the patients 
were Caucasian and 66.7 % were females.  Most of the study participants were unemployed 
(86.7%) and receiving social assistance such as Medicare or Medicaid (80.0%).  Slightly less 
than half (40%) were disabled and one-third were retired.  Three out of 15 participants were 
current smokers.  It is important to note that this is not inclusive of past smoking history.  Study 
participants were categorized by their NYHA class: the majority fell into NYHA class III 
(73.3%); 6.7 % NYHA Class I; 13.3% NYHA Class II; and 6.7% NYHA Class IV.  Furthermore, 
all 15 of the subjects were aha stage c. 
knowledge. 
There was a significant change in knowledge over time (F=15.6; p<.001; Table 2).  
Knowledge scores significantly increased from baseline (68.6) to 30-days (90) and 30-days to 
60-days (92.8).   
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self-efficacy: maintenance, management, and confidence. 
maintenance. 
Maintenance did have a significant statistical difference over time (F=10.7; P=0.002); 
statistically significant differences from baseline to 30-day and baseline to 60 days, but no 
significant difference in 30 to 60-day maintenance (Table 2). 
 management. 
  Management did not have a significant difference over time.  This was based on only four 
patients at all three points (Table 2).   
 confidence. 
 Confidence change over time was found to be significant (F=10.8; P= 0.002; Table 2). 
 readmission rate. 
 The findings of this study had 3- 30-day readmissions.   Fifteen patients completed the 
baseline, 30-day, and 60-day assessments.  However, two patients were unable to complete the 
study due to being readmitted prior to seven-day intervention.  Three out of the of the 15 study 
patients were readmitted for other reasons than heart failure exacerbation such as atrial 
fibrillation, chest pain, and hypotension, or changes in mental status.  The study attrition group 
had two patients readmitted before they could complete the study.  One of those two participants 
were readmitted directly for heart failure exacerbation.  Therefore, five total patients were 
readmitted within the 30-day time frame out of the attrition rate of 20 potential candidates.  This 
is a readmission average of 25 %.  The adjusted readmission average for the completed study 
sample (n=15) with readmissions (n=3) is an average readmission of 20 %.  
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The hospital wide patients who did not participate in the study had nine out of 55 heart failure 
related 30-day readmissions (16%) compared to three out of 15 readmissions in the study group 
(20%).  The hospital wide readmission data was only available from September 10, 2017 to 
January 31, 2018.   
 prevention diuretic. 
  5 out of 15(33.3%) patients required a prevention diuretic.  The diuretics patients received 
were torsemide, furosemide, and metalozone. 
 weight. 
 Changes in weight over time were only marginally significant (F=3.6; p=.057). 
 edema. 
 Non-significant changes were found in edema measurement (F=0.9; p= 0.4). 
Discussion 
Sample Characteristics  
Heart failure was stratified based upon class and stage.  The logical progression of 
disease indicates that every increase in stage or class increases the likelihood of 
readmissions (AHA, 2016).  However, this study contradicts most of evidence because of 
the sample size.  This study did not correlate the stage with readmission rate because all 
patients in the sample were AHA stage C.   Stage C is defined as structural heart failure 
and prior or current symptoms (AHA, 2016).  The study reiterates the literature 
recommendations for this population to receive a general yet individualized care plan.  
Furthermore, there was a higher prevalence of NYHA class III patients.  This class is 
defined by noticeable physical limitations.  Class III patients are comfortable at rest, but 
less than normal activity induces heart failure symptoms.   
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This is important because the risks of sudden cardiac death may increase with every 
escalation of NYHA class (Yancy et al., 2013; Novartis Pharmaceuticals, 2018).   
Additionally, this research supports the impact of smoking as a contributing risk 
and barrier to this population.  A barrier to reaching higher levels of self-care behaviors 
may relate to continued tobacco use (Beckie, Campbell, Schneider, & Macario, 2017).   
The three smokers in this study fell below 70 percent at different time intervals in the 
SCHFI scale.  The results in this study reinforce the recommendation of 70 % as a marker 
of adequate self-care levels.  This is important because patients who continue smoking 
may engage in less self-care activities such as exercise (Riegel et al., 2009; Beckie et al., 
2017).  Demographic variables can be used to indicate patients at high risk for heart 
failure. 
Most of the patients were unemployed and receiving social assistance.   
The mean age of the participants correlates with an increased prevalence in heart failure 
to be found in those greater than 65 years of age and those eligible to receive Medicare 
(Yancy et al., 2013).  The age demographics in this study and other studies indicate an 
aging and heart failure predisposed America.  By 2050, one out of five patients will be 
greater than 65 years old (Yancy et al., 2013).  The increasing likelihood of heart failure 
should alert stakeholders to implement the suggested multi-component interventions. 
Knowledge 
The increase in knowledge is significantly improved from patient’s baseline to 60-day 
follow up.  Future research may benefit from assessing knowledge earlier in diagnosis before 
inpatient discharge education.  The Atlanta Heart Failure of Knowledge test is a valid outcome 
variable to measure knowledge. 
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 This scale was rated excellent in clarity and relevance by a panel of nine heart failure experts 
(Reilly et al., 2009).  The implications of this study support use of the AHFKT as a baseline 
knowledge scale and a tool to navigate the initial and follow up education.  Over half of the other 
studies in a large meta-analysis provided printed teaching materials to patients (Baker et al., 
2011).  Printed materials aid in knowledge improvement and work as quick reference tools to 
improve patient engagement.  
Self-Efficacy 
The standardization of the SCHFI score is validated to readily disseminate 
evidence (Psotka et al., 2016).  Reigel et al., 2009).  In the management section, number 
14, “Take an extra water pill,” is a question that was found to be inapplicable for several 
participants.  A question in the confidence section that participants had difficulty 
understanding was “How confident are you to evaluate how well a remedy works?”  This 
jargon sometimes left patients confused about how to answer and use remedy in this 
context.  The results of this study imply that patients who have difficulties understanding 
this terminology may be at risk for reduced health literacy which can directly impact 
knowledge and self-care behaviors.  These patients may require additional education and 
home monitoring. 
Self-care behaviors are assessed with the SCHFI.  A score of 70 is associated with 
adequate self-care behaviors (Reigel et al., 2009).  Reigel et al. (2009) used the SCHFI to assess 
the relationship between an added telephone intervention and self-efficacy behaviors.  The 
literature associates SCHFI scores above the 50th percentile with a decrease in outcomes 
measured in this study: readmission and congestive heart failure exacerbation.  Cost was not 
measured as an outcome variable in this study.  
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 However, it is useful to recognize scores above the 75th percentile is associated with financial 
gains such as readmission rate reduction (Reigel et al., 2009).This research echoes previous 
recommendations for a multi-component effort to increase the above-mentioned variables.  
Higher self-care scores increase the likelihood of an effective transition from inpatient to 
outpatient heart failure management.  This study specifically identifies in-office education plus 
an added American Heart Association follow up tool to be an effective two-part intervention.   
Readmission Rate 
Hospital reimbursement directly relates to readmissions.  The initial heart failure 
admission costs approximately $11,000 (Qasim & Andrews, 2012).  The same source reports a 
heart failure readmission to cost approximately $13,000.  Hospital Care Data (2018) reports a 
national heart failure readmission rate of 22%.  According to Bergethon et al. (2016) and Qasim 
et al. (2012), one out of four patients will be readmitted within 30 days of discharge.  In 2006-
2011, the site of the study found heart failure as the highest cause of readmission (24.4 %) 
(Hospital Care Data, 2018).  The study site was found to have 350 heart failure specific 
discharges with 84 readmitted in 2013 to 2016.   This is above the benchmark readmission rate of 
22.4.  The results found in this study are comparable to national readmission statistics.  However, 
it is wise to continue initiatives to reduce readmission costs.  
Diuretic 
The number of patients that received a preventative diuretic did not have statistically 
significant decreases in 30-day readmission rates.  However, it is important to note that 33 
percent of the patients in this study did utilize a preventative diuretic.  Two out of the three 
patients readmitted received a diuretic.   
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This finding reiterates that the two-part intervention identifies and promotes early action to 
address additional diuretic needs.  This identification and timeliness benefits the prevention of 
heart failure exacerbation.  The group of five patients receiving an extra diuretic had three 
patients (60%) prevented from being readmitted.  This reinforces the need to improve patient 
engagement to be able to report symptoms earlier to providers to prevent readmission.   
The American Heart Association intervention tool has a section to assess if the patient 
would be an appropriate candidate for diuretic self-management.  However, this section does not 
define a specific protocol to identify patients to meet the criteria.  Future research is 
recommended to develop a standardized diuretic sliding scale tool for provider and patient use.  
This tool could be used in the outpatient setting and utilized in home health care of this 
population.  
Weight 
The changes in weight over the 60-day period were non-significantly increased based 
upon a significant p value equal or less than 0.05.  This is most likely due to diuresis at the recent 
hospital admission.  Therefore, the baseline office visit weight may be closer to a goal weight.  
The idea is to stay within two pounds of baseline weight.  Only three out of the 15 patients had 
weight gain greater than two pounds more than baseline at the end of the 60-day study.  The 
other 12 patients were within two pounds or below their baseline weight.  
Edema 
 The changes in edema had a non-significant positive occurrence in this population 
according to a p-value less than or equal to 0.05. It is important to note that generalization is 
limited in smaller sample sizes.  
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 All three (100%) of the patients readmitted were positive for edema at one or all three of the 
time points.  The telephone intervention allowed the primary investigator to discuss the 
individualized patient symptoms.  It is important to note that a generic question regarding ankle 
edema is not specific to all patients because edema or extra fluid may occur only as abdomen 
tightness.  The implications of assessing edema in this study reinforce importance of educating a 
patient to engage in a daily edema assessment.   
Limitations 
 A major limitation of this study is the sample size of 15 participants and of a single 
organization.  This sample is small, so the percentage weight of each participant accounts for a 
larger impact on the overall results.  The anticipated sample size was estimated to be 25-30 
patients.  An extension and modification of the time frame allowed for the new goal of 15 
participants.  The sample size may have been impacted by availability and the time frame of 
study.  Another limitation is the use of convenience sampling, because this may reduce 
generalization to patients outside of this hospital.  This study did not use randomization with a 
control group to increase its statistical significance because of feasibility.    
  Another limitation of this study is potential bias from patient reported results.  Also, the 
baseline scores were given to patients in office and then in office education was performed.  The 
provider education session was not altered.  However, educators and study participants were not 
blinded.  Therefore, this bias could impact the nature of discussion and questions.  Additional 
limitations could arise from paraphrasing items from the AHFKT and the SCHFI survey to ask 
the question in a way the patient understands.  There is potential for ceiling effect from high 
baseline scores in knowledge or self-efficacy (Baker et al., 2011; Shao et al., 2013).  These high 
scores may be attributed to recent hospital discharge teaching. 
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Principal Implications 
The research did not examine in-office education and the American Heart Association 
telephones follow up separately.  Therefore, this study is not able to attribute an increase in 
effectiveness to one intervention over the other (Rodriguez-Gazquez, Arredondo-Holguín, 
Herrera-Cortes, 2012).  Regardless, a patient may benefit from participating in individual or 
combined heart failure interventions.  This study supports additional action to improve heart 
failure knowledge and self-care behaviors.  Providers are already providing excellent education 
in the office setting but additional time is needed to reinforce and create sustainability.  
 The implications of this research impact local and national efforts by supporting a multi-faceted 
method to reducing heart failure disparities.  This will be accomplished with a vigilant approach 
to include an assessment of baseline knowledge and self-care.  An added telephone follow-up 
intervention within seven days is shown to have a statistically significant improvement on 
knowledge and self-care behaviors.   
Improving the above mentioned with the outlined interventions may decrease patient and 
organizational costs.  Costs are illustrated in financial costs and non-monetary costs such as 
quality of life and mortality rates.  If using the above recommendations to prevent 16 patients 
(20%) from being readmitted over four years then the potential costs saved would be $206, 880.  
This is only an example of possible savings to include payment of additional provider time to 
complete telephone follow up and the cost of materials (SCHFI and AHFKT).  This does not 
include other cost saving variables that may accrue throughout hospitalization.  These are 
potential not actual costs to go towards cardiac awareness campaigns such as heart fairs and 
cardiac screenings.  Also, the savings could go towards increasing patient access to heart clinic 
providers by creating more job opportunities.  Actual costs are recommended to analyze.  
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Nevertheless, a challenging factor remains patient compliance.  Compliance to heart failure 
clinic and telephone intervention remains a limitation and challenge in transition programs 
(Powers et al., 2014).  However, it is beneficial to transition patients with education to improve 
self-care and knowledge with an added telephone follow up by the American Heart Association. 
Future Quality Improvement 
This research has the potential to enhance community awareness of heart failure and the 
significant implications that self-care behaviors have on outcomes in this disease.   
The Plan-Do-Study-Act tool (Figure 2; Melnyk & Fineout-Overholt, 2015, pp. 83) and the 
Stetler Model of Evidence-Based Practice (Figure 3; Melnyk & Fineout-Overholt, 2015, pp. 278-
283) are the tools used to guide this research into a quality improvement recommendation.  The 
initial planning (PDSA-Step I) and preparation (Stetler Model-Phase I) required an assessment of 
the current process for heart failure patients at Baptist Health.  Patients were referred to the heart 
failure clinic by the inpatient team.  Next, the goal was for the patient to follow up after in-
hospital discharge.  
In the planning phase (PDSA-Step I) and the validation (Stetler Model-Phase II), an 
extensive review of the literature was completed to ensure tools to educate and assess self-
efficacy and knowledge.  The education was provided to providers and patients.  Next, a pretest 
and posttest was completed to assess self-efficacy and knowledge (PDSA-Step II; Stetler Model-
Phase III).  The 30-day readmission data was measured on the 15 patients who met the criteria.  
The next steps will be to educate providers, nurses, case management, and administration of 
study significance (PDSA Step II; Stetler Model Phase III).  The small-scale study highlights the 
benefits of a heart failure clinic follow up with an added telephone intervention.   
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The feasibility of implementing into practice will require further analysis of costs (PDSA-Step 
III; Stetler Model Phase III).  The first cost is the time of the provider and patient to perform the 
phone calls within seven days of in-office visit.   
 The next phase of this quality effort is to identify key stakeholders and act to form a 
team to continue piloting the research (PDSA-Step IV; Stetler Model Phase IV).  The goal date 
for the first team meeting will be May 21, 2018.  “Adopt, adapt, or abandon” (Melnyk et al., 
2015, pp. 211) will guide the decision to use the validated knowledge and self-efficacy scales in 
current practice.  These tests may not benefit all learning styles but can be positive when patients 
learn by application, question and answering, reading, and discussion.  The in-office education 
session entails the major talking points highlighted in the tests.  The established tools can be 
easily adopted into provider practice. 
The second recommendation is to repeat testing to assess sustainability (PDSA Step IV; 
Stetler Model-Phase IV) with a larger sample size (Baker et al., 2011; Wang et al., 2011; 
Norman et al., 2012; Rodriguez-Gazquez et al., 2012).  Future studies should consider expanding 
beyond one facility studies to be able to increase result generalization (Wang, et al., 2011).  The 
impact of smoking in this study identified a need to assess other comorbidities in the future.  
Furthermore, health literacy will be an important variable to evaluate.  Literacy was not studied; 
nevertheless, it was identified as a barrier both in the evidence and in this project (Baker et al., 
2011).  This source references the effect of poor health literacy on baseline knowledge and self-
efficacy.  Poor health literacy and self-care behaviors are improved when adding a telephone 
intervention in comparison to giving an overwhelming amount of information in a single face to 
face education session (Baker et al., 2011).  
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To enhance this research, it is recommended to expand the study to inpatients newly 
diagnosed with heart failure to gather a larger sample size and implement the AHA telephone 
intervention earlier after discharge.  Future studies should expand the sample to all heart failure 
patients instead of only those with a new diagnosis.  The expanded study should stratify the 
length of heart failure diagnosis to include the following classifications: zero to one year, one 
year to three years, three years to six years, six years to 10 years, and 10 years and above.  The 
SCHFI should define when a patient may need to take an extra water pill.  An example of this 
could be to take an extra furosemide tablet if you have weight gain greater than 2 pounds 
overnight.  Additionally, this can lead to further development of a flexible diuretic protocol 
(PDSA Step IV; Stetler Model-Phase IV).  The results of this study highlight barriers in patient 
reporting and weight monitoring to prevent all readmissions.  Therefore, it is recommended to 
use future research to assess home monitoring and advanced pulmonary artery pressure 
technology (CardioMEMS).  The advanced monitoring is recommended because it is likely that 
weight was not an early enough measurement of cardiac decompensation (Mangi, Rehman, 
Rafique, & Illovsky, 2017).  
These future study recommendations are stated because patients who achieve sufficient 
self-care behaviors may not require remote monitoring.  However, patients who fail to improve 
self-care or knowledge may benefit with home monitoring (Baker et al., 2011).  Furthermore, 
patients who show appropriate self-care and knowledge may benefit from developing flexible 
diuretic criteria.  This will lead to sustaining a practice change and a new approach in 
transitioning heart failure patients at the study site (PDSA Step IV; Stetler Model-Phase V).  
The improvement team should establish an action plan using the Stetler Model and a 
continuum of the PDSA cycle to sustain this research plan. 
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The site of research shares in the national vision to improve health disparities.  This is outlined in 
the site Community Health Needs Assessment goals (2015).  The first effort will target 
prevention and reduction of cardiac risks.  This can be accomplished by improving self-care 
behaviors of identified heart failure patients to reduce modifiable risk factors.  Examples of risk 
reducing strategies include smoking cessation campaigns, dietary modifications, and exercise.  
Second, detecting and treating risk factors such as hyperlipidemia, coronary artery disease, and 
chronic lung disease.  Third, a community partnership will enhance awareness and management 
of high risk groups such as this population.  The fourth goal echoes the central theme of this 
research intervention: educating the patient and community to improve self-care in chronic 
disease (Baptist Health, 2015).  This will be accomplished with sharing the findings of this study 
to stakeholders.  
Conclusion 
All levels of care are impacted by heart failure and readmissions.  The site of this study, 
Baptist Health Madisonville, is invested in addressing its own leading cause of hospital 
readmission (Hospital Care Data, 2018).  The significant increase in knowledge and self-efficacy 
can be used to support continued heart failure clinic follow up with the benefit of an added 
telephone intervention (Powers et al., 2014).  The Coleman Care Transitions Program reiterates 
that heart failure clinics reduce 30-day all cause admissions, and an added telephone follow up 
targets heart failure specific readmissions and mortality (Powers et al.,2014).   
The evidence provided in this study reveals a significant increase in self-efficacy and knowledge 
over time with transitioning to a heart failure clinic and an added telephone intervention.  
The research did not reveal a significant relationship between prevention diuretic use and 
30-day readmissions.  
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 This research did not indicate which component of the intervention was responsible for the 
significant increases in self-efficacy and knowledge.  The in-office education session stands 
alone in current practice.  The quality education provided in the session will be complemented 
with an added telephone intervention.  Overall, the research findings of this study were beneficial 
to support current heart failure clinic follow up at Baptist Health Madisonville.  The significant 
improvement in self-efficacy and knowledge suggest an opportunity to utilize this evidence to 
tackle the complexities of heart failure patients in a rural community.  
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Appendix A 
Search Strategy 
CINAHL Search Strategy 
 Search I.  The search used the first keyword of congestive heart failure and second key word of 
heart failure.  The screening of heart failure resulted in 12,960 articles.  Congestive heart failure resulted in 
1,375 articles, and Google search found 509,000 results; 21 articles were inclusive of the listed search 
methodology.  Quantitative articles were chosen from the titles relating to a program/intervention/education 
for heart failure improving outcomes or increasing a self-care behavior/quality of life or decreasing 
mortality or readmission.  This left 5 final articles to review.  Searching congestive heart failure resulted in 
1 result after advancing search with keywords: implementation, transition, or transition of care.  
Search II.  Identified key words of heart failure, congestive heart failure, or cardiac dysfunction 
and screened 13,299 articles.  A search for transition, discharge, or follow up interventions found 306 
results.  The combination of search 1 and 2 resulted in 2 results.  A google search of the combination found 
103,000 articles.  Eligibility limited to Boolean phrase and published: 20120101-20161231 and resulted in 
2 qualifications.  Only 1 study by Feltner (2014) would be included in final results based upon desired level 
of evidence. 
PUB MED Search Strategy 
Search I.  The keywords are congestive heart failure and heart failure with a goal for identifying 
studies specific to country or rural areas.  The screening began with searching for congestive heart failure 
or heart failure resulting in 892 studies.  There was 1 final article after adding self-efficacy or self-care to 
search with the mentioned criteria.  A google search found 39,600 results.  
Search II. I broadly searched MESH terms in pub med database for cardiac dysfunction or heart 
failure with 3945 results.  Next, 2 articles were found after adding intervention or management program 
AND secondary or tertiary prevention.  The 2 eligible were evaluated to eliminate 1 article not specific to 
heart failure or cardiac dysfunction.  This resulted in 1 final article.  
Search III. A broad search throughout Pub Med using the terms heart failure education program 
evaluation resulted in 259 results.  A broad google search found 526, 000 results.  The 259 articles found 
on pub med were scrutinized by the mentioned search methodology to include 13 articles.  These 13 
articles were assessed to eliminate studies not specific to post hospital or only heart failure.  The other 
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articles addressed inpatient or multiple co morbidities targeted such as atrial fibrillation or diabetes which 
are not a part of this study.  This resulted in 4 final studies.  
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Appendix B 
Comprehensive Literature Review Table 
 
ARTICLE 1: Dracup, K., Moser, D. K., Pelter, M. M., Nesbitt, T. S., Southard, J., Paul, S. M., & ... Cooper, L. S. (2014).  Randomized, controlled trial to improve self-care in 
patients with heart failure living in rural areas.  Circulation, 130(3), 256-264 9p. doi:10.1161/CIRCULATIONAHA.113.003542 
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on group 
or control 
group 
from 
baseline 
or over 
time 
(p=0.199) 
 
QOL:  
Level = II  Strengths: 
 
- ↑ SC 
 
-CD NSD with single education 
session 
 
-results are consistent with studies 
observing the effects of single HF 
education sessions  
 
 
NSD in QOL with the 
education/follow-up intervention 
which matches with other single 
education session studies about HF 
care on QOL 
 
 
Limitations:  
 
-QOL and Care dependency were not 
↑study and nurses will have to apply 
other measures  
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calls)+ 
SMT 
3.fluid 
watchers 
(PLUS) 
(biweekl
y calls 
until RN 
says 
compete
nt on 
self-care) 
+ SMT  
time effect 
was 
significant 
at  
 p = 0.  
00017  
 
but QOL 
with time-
interventi
on was 
not 
significant 
at p = 
0.203. 
 
QOL 
improved 
after 3 
months in 
both 
groups 
BUT in 
interventi
on group= 
the QOL 
physical 
limitation  
was not 
significant 
p=0.021); 
nor the 
social 
limitations 
= 0.123) 
did not 
improve 
statisticall
y level 
The sample did not represent all HF 
patients due to excluded ICD or CRT 
within 3 months of recruiting.  
-a single study at one center by one 
primary investigator leaving room for 
bias by the investigator in positive 
effects of SCB & results may vary/not 
externally valid to generalize in 
another setting.  There may be 
socially desired answering related to 
the questions were assessed after the 
follow-up phone call. 
 
  
Risk or harm if implemented: NR  
 
 
Feasibility of use in your practice: 
teach/apply in practice given the 
results positively affected patient self-
care behavior with the education 
intervention and the follow up to get 
the patient involved in their care 
using SCP.  
-patient engagement in their care 
plan/health=reduced readmissions  
-Education is vital SOONER than 
later post discharge.  
-shows need for interventions/studies 
to support ↑ care dependency and 
QOL  
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after 
Bonferron
i 
Correction
.  
 
RCT= randomized controlled trial; SMT= standard medical treatment; SC/B = self-care/behavior; QOL= quality of life; CD/S=Care Dependency/ Scale; KCCQ=Kansas City 
Cardiomyopathy Questionnaire; CD= cardiac death; EI=education intervention; RH= rehospitalization; NR= not reported 
 
 
ARTICLE 2: Norman, J. F., Pozehl, B. J., Duncan, K. A., Hertzog, M. A., & Krueger, S. K. (2012).  Effects of exercise training versus attention on plasma B-type natriuretic 
peptide, 6-minute walk test and quality of life in individuals with heart failure.  Cardiopulmonary Physical Therapy Journal (American Physical Therapy Association, 
Cardiopulmonary Section), 23(4), 19-25 7p. 
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Author 
Year 
Title 
Norman, J., et 
al. (2012).  
Effects of 
exercise 
training versus 
attention on 
plasma B-type 
natriuretic 
peptide, 6-
minute walk 
test and quality 
of life in 
individuals 
None 
 
 
RCT 
 
Purpose: 
secondar
y 
analysis 
of 
HEART 
CAMP 
interventi
on for 
impact of 
exercise 
versus 
attention 
on HF 
using 
N= 42 
patients 
with 
NYHA 
Class 
II-IV 
CHF.  
 
> 21 
years of 
age; (2) 
oriented 
to 
person, 
place, 
and 
time; 
IV1 = 
exercise  
 
IV2= 
education 
only on 
HF 
 
DV1 
=BNP 
markers 
 
DV2= LV 
wall stress 
 
DV3= 
QOL in 
 group baseline 
measures = 
chi-square and 
t-test 
 
each 
intervention 
measurement 
used non-
normality and 
outliers  
 
BNP= 
logarithmic 
transformation 
 
traditiona
l 
repeated-
measures 
ANOVA 
 test  
 
 
BNP=me
an log 
transfor
med  
 
Time and 
Group X 
Time = 
mean 
BNP 
levels 
(baseline, 
12 & 24 
weeks) for 
both 
groups: 
EX: SD ↑ 
in BNP 
levels at 
the end of 
24 weeks 
= p 0.03 
Versus the  
AT-C 
group= p 
0.44 NSD  
Level = II     
 
Strengths: 
- education alone did not improve 
BNP 
- exercise training did not worsen LV 
function 
- attention alone can have a positive 
impact of QOL over time but exercise 
will increase and have greater effect 
- 6 MWT increased farther distance in 
EX group  
- Clinical finding to support education 
on support groups, education, and 
exercise programs when patients are 
candidates.  
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with heart 
failure. 
KCCQ to 
assess 
QOL, 6-
minute 
walk 
test(6-
MWT) in 
relation 
to 
physical 
assessme
nt & 
BNP 
levels at 
baseline, 
12, and 
24 weeks 
 
Randomi
zed 42 
stable 
CHF 
patients 
to 2 
groups: 
GROUP 
1= (EX)  
 
GROUP 
2= (AT-
C) 
 
 
 
(3) able 
to speak 
and 
read 
English; 
(4) 
resting 
left 
ventricu
lar 
ejection 
fraction 
>40%; 
and (5) 
stable 
on 
optimal 
medical 
therapy 
for at 
least 30 
days.  
 
 
Attritio
n 
rate(dro
pout):  
40 of 42 
recruite
d 
particip
ated in 
24-
week 
study; 4 
dropout
s of EX 
group in 
chronic 
HF  
 
DV4= 6-
mwt 
Significance 
level of a type 
1 error based 
on a 
0.1(typically 
0.05) 
square of 
the 
Cohort 
(Group) 
X Time 
effect as 
the 
denomin
ator 
(df=2,8) 
 
effect 
size: n2 
calculate
d using 
total 
within-
subjects 
sum-of-
squares 
as the 
denomin
ator 
 
 
 
 
6-MWT: 
NSD after 
24 weeks 
(p=0.41) 
 
EX ↑ 
(55.7 
meters of 
change 
versus the 
AT-C 
group 
32.3 
meters 
 
QOL= 
NSD 
between 
the AT-C 
and EX 
group p = 
0.20 
 
 
X Time 
interaction
=SD (p 
= .07).  
Simple 
main 
effects 
tests SD 
.03  
But not 
for the 
AT-C= p 
= .44 
 
Limitations:  
Small group mostly Caucasian so 
could be racial bias or threat to EV 
- unable to test diastolic dysfunction 
given this sample had systolic 
dysfunction 
to individuals with diastolic 
dysfunction is not known.  
 
-small sample size did not incorporate 
“nested” aspect into analysis; 
suggesting a larger sample to use 
linear mixed method models  
-this study did not have unstable 
patients post coronary interventions 
or with EF less than 40 %.  This 
exclusion is to be considered in 
treatment and use caution in special 
cases that could be considered 
unstable.   
 
 
 
  
Risk or harm if implemented: NR 
 
 
 
Feasibility of use in your practice:  
 Can apply the principals of exercise 
therapy and programs in combination 
with education to ↑ outcomes 
(distance, QOL) in systolic 
dysfunction patients as tolerated 
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follow-
up time  
 
 
 
BNP: AT-
C group 
(education 
and 
normal 
living 
only with 
no added 
exercise 
interventi
on) NSD 
in BNP 
 
LV wall 
stress= 
NSD 
exercise 
did not 
have 
negative 
effect on 
LV 
function  
 
↑QOL 
with AT-
C 
education 
only but 
improved 
with 
combining 
AT-C 
(education 
only 
group) 
with 
exercise  
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6-MWT: ↑ 
distance in 
both; but 
SD in EX 
group.   
RCT= randomized controlled trial                        
QOL= quality of life 
KCCQ=Kansas City Cardiomyopathy Questionnaire 
NYHA= New York Heart Association 
NR= not reported 
EX =Exercise Training Group  
AT-C= Attention-Control Group 
B-type naturetic peptide = BNP 
HEART CAMP = Heart failure Exercise and Resistance 
Training CAMP 
EV=external validity 
ARTICLE 3: Rodriguez-Gazquez, M., Arredondo-Holquin, E., & Herrera-Cortes, R. (2012).  Effectiveness of an educational program in nursing in the self-care of patients 
with heart failure: randomized controlled trial.  Revista Latino-Americana De Enfermagem (RLAE), 20(2), 296-306 11p. doi:10.1590/S0104-11692012000200012 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Rodriguez-
Gazquez, M., 
et al. (2012).  
Effectiveness 
of an 
educational 
program in 
nursing in the 
self-care of 
patients with 
Dorothea 
Orem's self-
care deficit 
theory' 
RCT 
 
 
 
N= 63 
patients 
 
Control 
= 26 
patients 
Interven
tion = 
29 
IV1 = EI 
(Educatio
nal 
interventi
on) 
 
DV = 
SCB in 
HF 
SPSS software, 
version 19.00 
(Chicago, 
USA) used  
 
four-part 
instrument 
formed: 1. 
Demographic 
information 
Absolute 
differenc
e:  
 
NNT 
(number 
needed 
to treat) 
 
n= 70% of 
patients in 
the study 
group 
versus 
30% in 
the control 
group, 
who ↑ 
Level = II Strengths: consistent findings along 
with other resources in family support 
being a positive influence in SCB 
outcomes 
 
logistic regression analysis showed a 
positive relation between educational 
level and ↑ SCB consistent with other 
research report 
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heart failure: 
randomized 
controlled trial  
patients
; (55 
after 
dropout
s) 
  
> 30 
years of 
age who 
in a 
cardiov
ascular 
health 
progra
m in 
Medellí
n 
(Colom
bia) 
with a 
HF 
Diagnos
is with 
sympto
ms, 
echocar
diogram 
results, 
&  
NYHA 
class I 
to III 
 
Study 
lasted 9 
months  
 
AR: 8 
(age, gender, 
marital status, 
occupation, 
education) 
2. social 
support 
(family, 
friends, health 
institution)  
3. Clinical 
information 
(comorbidity, 
functional 
class, EF, 
hospitalization, 
death. 
4. Artinians 
Heart Failure 
Self-Care 
Behaviors 
Scales  
(created from 
Dorthea 
Orem's self-
care deficit 
theory) and  
validated to 
use with 
Cronbach’s 
alpha of 0.76 
(men: 0.73 and 
women: 0.77) 
for Colombia 
SCB 
improve
ment 
percenta
ge: 
 
AD 
(absolute 
differenc
e) 
SCB by at 
least 20% 
 
AD= ↑ 
SBC score 
by 20 % 
 
 
 The NNT 
found was 
2.5,  
After 
receiving 
interventi
on for at 
least 
seven 
months, 
one in 
every 2.5 
patients 
would 
improve 
SCB score 
by 20%   
Limitations: uncertain to which 
educational interventions more 
strongly influenced the 
Change in self-care scale scores, 
which could be used in further 
research. 
 
Needs ↑ follow-up than 9-month 
follow-up to prove nursing education 
↓ readmission 
-  
 
-NSD gender differences in functional 
state unlike others which can be 
accounted for the variables monitored 
in this study based on functional 
class/level.  Women in other studies 
could have had different variables… 
↓ functional abilities = ↓ SCB.   
 
-NSD in age which has conflicting 
views with other research that 
supports and others that found age is 
associated ↑ probability of turning to 
the physician for SCB factors. 
 
 
 
Risk or harm if implemented: NR 
 
Feasibility of use in your practice: 
 
A nursing educational 
intervention/education piece such as 
this can improve self-care behaviors 
in HF patients.  Which intervention 
best improves SCB is not known but 
a combination could be implemented 
for best outcomes  
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EI= Educational intervention including disease knowledge, adherence treatment request for help during the disease, adaptation to life with disease, effects of medication, 
patients' 
empowerment and management of disease; and resources to adapt to life with the 
disease 
 
 
 
ARTICLE 4:   Shao, J., Chang, A. M., Edwards, H., Shyu, Y. L., & Chen, S. (2013).  A randomized controlled trial of self-management program improves health-related 
outcomes of older people with heart failure.  Journal of Advanced Nursing, 69(11), 2458-2469 12p. doi:10.1111/jan.12121 
          
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Shao, J. et al. 
(2013).  A 
randomized 
controlled trial 
of self-
management 
program 
improves 
health-related 
outcomes of 
older people 
with heart 
failure 
None RCT HF 
patients 
in 
norther
n 
Taiwan 
at 
Cardiac 
Clinics 
during 
October 
2006-
May 
2007  
 
N= 93 
randomi
zed to 2 
control 
groups: 
control 
= 46 
 IV1 = 12-
week 
SMP that 
emphasize
d self-
monitorin
g of 
salt/fluid 
intake and 
HF related 
symptoms 
 
DV = SE 
for salt 
and fluid 
control 
and SMB 
in HF  
 Data were 
collected at 
baseline as 
well as 4 and 
12 weeks later.  
Data analysis 
to test the 
hypotheses 
used repeated-
measures 
anova models 
 
HFSmB scale 
and HFSD = 
English and 
Chinese trans 
culture 
translation/vali
dity 
 
 
 
P values  
-mean 
SeSFC 
score 
↑between 
time 1 & 2 
and 1 & 
3(P < 
0.001)  
 
-HFSmB 
scores p 
value 
0.001 
 
HFSmb-
NSD P 
value for 
Time 2 & 
Time 3 
 
HFSD 
scores 
Level = II Strengths  
-used Bandura’s four primary sources 
for information  
 
Limitations: 
-in 2 Taiwan medical centers- culture 
bias 
 
-uncertain which intervention ↑SE 
 
-needs a longer study or follow-up for 
assessing health service use  
-ceiling effect-findings supported 
with this study referencing a 
systematic review (Ditweig et al. 
2010)  
with conflicting report of 
improvement in HB (Elzen et al. 
2007)  
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Interven
tion = 
47  
 
 
Attritio
n rate & 
why?  
IG= lost 
7 to 
follow-
up 
CG=los
t 8 to 
follow-
up  
majorit
y of 
particip
ants 
declinin
g to 
continu
e with 
no 
reason 
provide
d 
 
Time 1 
&2; 1 & 
3= P 
<0.001; 
 
NSD for 
time 2 & 3 
 
Health 
service 
use-
p=0.76 
NSD in 
CG or IV  
 
 
 
 
 
 
Risk or harm if implemented: NR 
 
 
Feasibility of use in your practice  
HF patients receiving 
the self-management intervention ↑ 
SE  
for controlling salt and fluid intake, 
changed HF-related 
Behaviors, & ↓ HF-related symptoms.   
SE= self-efficacy 
SESFC = self-efficacy for salt and fluid control 
HFSmB = HF self-management behavior  
HFSD=Heart failure symptom distress 
IG=intervention group 
CG= control group 
IV=independent variable 
DV= dependent variable  
SMB=self-management behavior  
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SMP= designed to enhance self-management by promoting self-efficacy through four primary sources of information: mastery of experience, social modelling, social 
persuasion, and awareness of physical and emotional states.  Interventions were five sessions: home visit within3 days after enrolment, telephone follow-ups at 1, 3, 7, and 11 
weeks, completion of a diary of daily sodium and fluid intake and daily self-recording of weight 
 
 
 
ARTICLE 5: Baker, D.W., Dewalt, D.A., Schillinger D., Hawk V., Ruo B., Bibbins-Domingo K.,…Pignon, M. (2011).  The effect of progressive, reinforcing telephone 
education and counseling versus brief educational intervention on knowledge, self-care behaviors and heart failure symptoms.  Journal of Cardiac Failure, 
17(10):789-96.  doi: 10.1016/j.cardfail.2011.06.374.  
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Baker, D.W., 
Dewalt, D.A., 
Schillinger D., 
Hawk V., Ruo 
B., Bibbins-
Domingo 
K.,…Pignon, 
M. (2011).  
The effect of 
progressive, 
reinforcing 
telephone 
education and 
counseling 
versus brief 
educational 
intervention on 
knowledge, 
self-care 
behaviors and 
heart failure 
symptoms.  
Journal of 
N/a  RCT 
 
 N= 601 
MA= 
61 y.  
 
Margin
al or IA 
literacy
= 37 %  
 
EF < 
45= 69 
% 
CLASS 
III to IV 
 
sympto
 IV 1 = 
TTG 
 
IV 2 = 
BEI (Brief 
1-hour 
education 
session) 
 
DV = 
which IV 
provides 
better 
outcomes 
for HF-
related 
quality of 
life 
(HFQOL), 
SAS (version 
9.2; Cary, NC).  
Assessed for 
randomization 
to check for 
response bias 
between the 2 
groups IV 1 vs 
IV 2 
(demographics
) 
. 
Independent T 
-tests = 
continuous 
variables  
chi-square tests 
=categorical 
variables.  
 
 
P value 
 
means 
 
standard 
deviation 
 
 
TTG= ↑ 
knowledg
e and salt 
monitorin
g P<0.001 
 
SCB ↑= 
P= 0.001 
increased 
from 
mean 4.8 
to 7.6 
TTG vs 
5.2 to 6.7 
for BEI 
(1-hour 
brief 
education 
session)  
Level = II Strengths  
 
 benefit in the extended  
counseling more so than 
 the brief education.   
Nevertheless, there is 
 benefit found in an 
 education intense class. 
  The continued phone calls provided 
better outcomes for quality of life and 
self-care behaviors 
  
 TTG program was 
 equally efficacious 
 for patients with inadequate/marginal 
 literacy as for those with  
adequate literacy 
 
Limitations 
-study utilized many 
 patients who had higher 
 literacy levels 
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Cardiac 
Failure, 
17(10):789-96 
ms= 31 
% 
knowledg
e, and SE. 
TTG 
(teach to 
goal) = A 
30-day 
telephone 
counselin
g done 
over 5 to 8 
phone 
calls. 
Education 
on 
adjusting 
diuretics 
to 
symptoms
, behavior 
managem
ent and 
support 
group 
versus 
BEI  
  
  
 
Paired t tests= 
changes in 
knowledge, 
SE, SCB, and 
HFSS scores 
between 
baseline and 1-
month follow-
up for each 
study group  
 
Independent 
sample t 
test=difference
s in the change 
between the 
groups 
 
 
 
  
 
HFQOL ↑ 
P < .001 
SD in 
difference 
between 
TTG 
AND BEI  
 
 
improved 
fin TTG 
IV-group 
= 58.5 to 
64.6  
 
and NSD 
in 
HFQOL 
IN BEI 
group 
(64.7 to 
63.9) 
 
 
  
the BEI group probably 
 received more intensive 
 education than the “normal” 
therefore the TTG 
intervention could be much 
greater outcomes.  
However, the TTG 
intervention could be overestimated. 
 
 
Unsure if the HFQOL  
was higher in the TTG  
group due to a greater 
 improvement in knowledge, 
 SE, SCB, or other direct  
effect of the intervention  
  
Risk or harm if 
 implemented=  
None identified 
 
Feasibility of use in  
your practice=   
still unclear on benefit  
of single session education, structured 
follow-up  
telephone calls to reinforce teaching 
goals and self-care behaviors, and 
more 
 intensive remote  
monitoring by health  
professionals.  
 
Baker (2012) finds that 
 follow-up telephone calls 
 (without remote monitoring of signs 
and symptoms) 
 incrementally improve 
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 knowledge, SCB, and HF symptoms 
beyond a single, intensive face-to-
face  
teaching session; 
 
Patients with low literacy 
 can benefit by increasing 
 their SCB 
 
Longer evaluation need to 
 assess sustainability of SCB, reduced 
hospitalization, monitoring, and 
death. 
 
 
Patients who master SCB 
 may remove need for remote 
monitoring HOWEVER  
those who fail to increase 
 SCB may greatly benefit  
from remote monitoring 
 
SE= self-efficacy  
RM=role modeling 
PV02= peak exercise test peak oxygen uptake 
 
ARTICLE 6: Powers, J. S., Cox, Z., Young, J., Howell, M., & DiSalvo, T. (2014).  Critical Pathways: Implementation of the Coleman Care Transitions Program in Individuals 
Hospitalized with Congestive Heart Failure.  Journal of The American Geriatrics Society, 62(12), 2442-2444 3p. doi:10.1111/jgs.13174 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
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Powers, J., et 
al. (2010).  
Critical 
Pathways: 
Implementatio
n of the 
Coleman Care 
Transitions 
Program in 
Individuals 
Hospitalized 
with 
Congestive 
Heart Failure.  
 
Transitions of 
Care Model 
RCT 
  
 
Candidat
es 
consente
d and 
were 
randomiz
ed.  Saw 
patients 
prior to 
discharge
, 
educatio
n/counsel
ing on 
medicati
on,  
 
 
n= 10  
7 
receive
d at 
least 1 
of the 4 
visits 
 
41 % 
attrition 
rate due 
to 
particip
ant or 
caregiv
er 
declinin
g 
interven
tion, 
inability 
to 
contact, 
or post-
acute 
care 
facility 
  
-
Patients 
admitte
d to 
Acute 
Care for 
Elderly 
or HF 
service 
at VUH 
IV= 4 
contacts 
(2 home 
visits and 
2 phone 
calls with) 
 
CG= 
standard 
of care 
 
DV1= 90-
day 
mortality 
rate  
 
DV2= 30-
day 
rehospitali
zation 
 
 
Katz Index of 
Activities of 
Daily Living 
 
 
Acute 
Physiology and 
Chronic Health 
Evaluation II 
(APACHE II) 
percenta
ge  
 
n=sampl
e  
90-day 
mortality 
=14%. 
 
(11)38% 
CG 
received 
HC 
  
-(16)63% 
30-day FA 
 
-54% of 
30-day 
return 
visit 
attendance 
rate for 
VHFP. 
 
 IG (full 
or partial 
interventi
on) five 
(29%) HC 
 
13 (81%) 
FA within 
30 days.  
 
-IG (10 
patients) 
full 
interventi
on = 90% 
30-day FA 
& 70% 
within 14 
days. 
Level =II  Strengths  
-Randomized 
-similar CG and IG characteristics 
  
 
Limitations 
Coaches had occasional problems 
contacting MD for new symptoms.  
Needed support from nursing and 
pharmacy to reeducate participants 
and caregivers regarding meds 
Only 10 full IG participants 
-↑ following up post discharge are a 
negative factor in readmissions.  The 
perceptions should be measured of the 
patients in future research to ↑ 
resources & retention.  
Risk or harm if implemented=NR 
 
Feasibility of use in your practice  
Transition patients into discharge or 
home care with proper education and 
resources prior to discharge and 
follow up is essential. 
 
↓ Possible barriers to follow up  
 
Educate importance with recognizing 
symptoms early and how this can ↓ 
readmits/ mortality.  
 
-use with SCP with appropriate 
transitions of care/follow 
up/symptoms  
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in the 
Greater 
Nashvil
le area. 
 
no 
difference 
in 30-day 
repeat 
hospitaliz
ations IG 
or CG 
FA= follow-up appointment 
HC-home care 
VUH= Vanderbilt University Hospital 
VHFP= Vanderbilt Heart Failure Program 
ARTICLE 7: Lofvenmark, C., Saboonchi, F., Edner, M., Billing, E., & Mattiasson, A. (2013).  Evaluation of an educational program for family members of patients living with 
heart failure: a randomized controlled trial. 
Journal of Clinical Nursing, 22, 115–126, doi: 10.1111/j.1365-2702.2012.04201.x 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Lofvenmark, 
C., Saboonchi, 
F., Edner, M., 
Billing, E., & 
Mattiasson, A. 
(2012).  
Evaluation of 
an educational 
program for 
family 
members of 
patients living 
with heart 
failure: a 
randomized 
controlled trial. 
 
1.SS  
 
2. SOC (3 
parts of 
comprehensib
ility, 
manageability 
and 
meaningfulne
ss) 
RCT 
 
Purpose: 
a 
GBMPE
P for 
family of 
CHF 
patients 
related to 
QOL, D 
& A. 
Secondar
y aim= 
SS & 
SOC on 
changes 
in QOL, 
n=128 
FM 
 
FM 
defined 
as 
living in 
same 
househo
ld or 
patient’
s choice 
 
Inclusio
n 
criteria
=adult 
family 
IV1= 
MPP 
 
IV2= 
interaction 
forum for 
family to 
interact 
(support 
each 
other) 
 
DV1=A & 
D 
 
DV2= 
QOL  
 -HADS 
measured 
A&D 
 
-ISSI scale-
measured 
social network  
 
-SOC scale-
sense of 
coherence 
measurement 
 
-Cantril Ladder 
of Life 
measured QOL 
 
P value  FM age 
=SD with 
QoL (p < 
0.001)- 
younger 
family= ↑ 
QOL 
 
-living 
with pt 
had 
𝑙𝑜𝑤𝑒 ↓
𝑟 QOL 
than those 
(p value    
= 0.012) 
 
 
Level = II Strengths – 
 
A social support structure of ADSI = 
worsened levels of emotional 
distress over time.  If there is not 
support and motivation then care 
giver burden for CHF patients 
increased.  
 
Disease knowledge does not target 
anxiety, depression, and QOL.  There 
needs to be specific support and 
further research in this area.  
Sometimes increasing the knowledge 
results in worsened sense of control.  
We should target this aspect of 
education and improve patient’s 
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and D & 
A  
 
 
Consente
d, 
randomiz
ed, 
baseline 
question
naires 
 
8 
participa
nts in 
each 
group, 
met 6 
times for 
2-hour 
session 
for 6 
months 
in 
hospital 
room.  
 
CG – 
given 
regular 
routine 
self-
care/CH
F 
educatio
n at 
hospital 
member
s’, ‡18 
years, 
of 
patients 
with 
CHF 
who 
had 
been 
treated 
in 
hospital
.  
-
Exclusi
on 
criteria 
were 
patients 
with 
planned 
heart 
operatio
n or 
other 
serious 
disease 
-setting 
a 
hospital 
Stockho
lm area 
from 
2004–
2006 
 
Attritio
n rate:  
- SWED-
QUAL-health 
related QOL 
scale 
 
Validity/reliabi
lity= 
Cronbach’s a-
coefficient 
 
mixed model 
analyses of 
covariance 
(ANCOVA)  
 
-Bivariate 
correlation 
analyses w/ 
Spearman’s 
correlation to 
check cross-
sectional 
relations 
between A&D, 
and  
QoL 
Depressio
n c, ADSI 
and 
ADAT. 
Regarding 
QoL, SD 
in AVSI 
and age of 
FM.  
 
-NSD in 
pt and FM 
variables 
of D & A 
between 
CG or IG 
 
 
family member senses of control and 
emotional wellbeing.  
 
Limitations= a high number of 
patients did not permit us to ask their 
family members to 
participate in the study; sample 
compromise 
 
- Non- significant outcomes possibly 
due to outcome variables were 
not specifically targeted by the 
intervention.  
 
Risk or harm if implemented: NR 
 
Feasibility of use in your practice  
 
-D&A did not ↓ nor did QOL ↑ after 
IV of an educational program.  
Education does help improve QOL, 
sense of control, and emotional 
wellbeing in patients.  
 
-An individual’s social support is vital 
in A & D, and QOL in the CHF 
family member.  It is essential for the 
practitioner to consider this in the 
care of family and patient.  
 
-A program for family specifically 
targeting D&A and QOL should be 
researched ↑ those outcomes.  
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family 
member
s 
eligible
= 293 
(157 
decline
d 
particip
ation & 
other 
reasons) 
 
Initial 
randomi
zed 
CG= 63 
at start; 
final 
CG= 51 
after 
dropout
s from 
stoppin
g or 
death 
from 
FM or 
patient. 
 
Initial 
Rando
mized 
IG=65 
at start; 
final IG 
= 54 
after 
dropout
 50 
 
s from 
unknow
n, did 
not 
attend 
sessions
, 
decease
d, and 
moved  
GBMPEP= Group-based multi-professional educational program 
QOL=quality of life 
FM=family member 
D & A= depression and anxiety 
SS= social support 
SOC= sense of coherence  
 HADS= Hospital Anxiety and Depression Scale 
Interview Schedule for 
Social Interaction(ISSI) scale 
(MPP)Multi-professional Program includes: cardiologist; self-care (specialist nurse in CHF), nutrition (dietician), physical activities (physiotherapist) and psychosocial 
aspects (social worker 
AVSI= availability of social interaction; ADSI= adequacy of social interaction; AVAT= availability of attachment; ADAT=adequacy of attachment; SOC= sense of coherence 
 
ARTICLE 8: Stewart, S., Chan, Y., Wong, C., Jennings, G., Scuffham, P., Esterman, A., & Carrington, M. (2015).  Impact of a nurse-led home and clinic-based secondary 
prevention program to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized 
controlled study.  European Journal of Heart Failure, 17(6), 620-630.  doi:10.1002/ejhf.272 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
 51 
 
Stewart, S., et 
al. (2015).  
Impact of a 
nurse-led 
home and 
clinic-based 
secondary 
prevention 
program to 
prevent 
progressive 
cardiac 
dysfunction in 
high-risk 
individuals: 
The Nurse-led 
Intervention 
for Less 
Chronic Heart 
Failure (NIL-
CHF) 
randomized 
controlled 
study.   
Theoretical 
basis for 
study 
RCT 
with 
blinded 
endpoint 
adjudicat
ion  
 
Led by 
cardiac 
specialist 
nurse  
 
inclusion
: cardiac 
inpatient
s aged 
≥45 
years 
screened 
& 
discharge
d to 
home 
(located 
within a 
40-km 
radius of 
the 
hospital) 
with a 
cardiovas
cular 
diagnosis 
(majority 
CAD 
confirme
d by 
coronary 
angiogra
624 
cardiac 
inpatien
ts in a 
cardiac 
speciali
st center 
in 
Melbou
rne, 
Australi
a (66 ± 
11 
years, 
71% 
male, 
and 
70% 
with 
CAD) 
randoml
y 
allocate
d (1:1) 
SOC or 
IG.  
 
CG= 
310  
 
IG= 
301 
 
Attritio
n Rate: 
CG= 
44(14%
) ended 
follow-
 
IV=home 
visit at 7–
14 days 
post-index 
discharge 
with a 
patient-
centered 
approach/ 
individual 
& 
contextual 
factors 
education 
 
DV1= 
New CHF 
hospitaliz
ation or 
all-cause 
mortality  
 
DV2= rate 
of 
emergenc
y and 
cardiovasc
ular 
(emergenc
y or 
elective) 
hospitaliz
ation 
and 
related 
stay 
during the 
CONSORT 
guidelines for 
pragmatic trials 
 
SPSS 19.0 and 
STATA 11.  
Significance = 
P < 0.05 (two-
tailed) 
 
Primary 
endpoint data 
were used to 
generate 
Kaplan–Meier 
survival 
curves/ 
analyzed with 
the log-rank 
test.  
 
-Between-
group 
(univariate) 
comparisons 
were assessed 
by Student’s t-
tests, 
Mann–
Whitney U-test 
(for non-
normally 
distributed 
continuous 
data) 
-𝜒2 test [with 
calculation of 
odd ratios 
percenta
ge 
 
odds 
ratio 
 
CI 
 
p value  
NSD in 
cardiovasc
ular-
related 
and 
emergenc
y 
hospitaliz
ation 
between 
IG and 
CG. 
 
 The NIL-
CHF 
group 
accumulat
ed 478 
(0.214 ± 
0.70 vs. 
0.095 ± 
0.284 
days/parti
cipant/mo
nth; P = 
0.052) and 
1097 
fewer 
days of 
hospital 
stay 
(0.391 ± 
1.80 vs. 
0.199 ± 
0.47 
days/parti
cipant/mo
nth;  
Level = II Strengths = 
The NIL-CHF intervention = NSD in 
preventing CHF & readmission.  
 
Intervention of NIL-CHF is 
associated with ↓ LOS & ↑ CF long 
term 
 
Limitations 
ineffective in de novo CHF 
hospitalization or death within a 
cohort of cardiac inpatients with high 
levels of cardiac dysfunction, during 
3–5 years follow-up 
 
-ineffective in preventing recurrent 
hospitalization  
- -consistent with previous findings 
for this intervention, a positive 
difference was found to be associated 
with ↑ recurrent stay in unplanned 
(statistically significant) and 
cardiovascular-related (borderline 
significant) hospitalization  
 
 
Risk or harm if implemented: NR 
 
 
Feasibility of use in your  
practice  
 
 
the NIL-CHF intervention must be 
regarded as an ineffective CHF 
prevention strategy 
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phy 
and/or 
diabetes 
mellitus) 
requiring 
active 
treatment 
but not 
CHF as 
defined 
by 
contemp
orary 
guideline
s 
 
Exclusio
n: no 
preexisti
ng CHF; 
excluded 
if CHF 
related 
admissio
n 30 days 
after 
discharge 
 
up; 23 
(7.3%) 
died 
 
IG= 
36(12%
) ended 
follow-
up; 
24(7.7
%) died 
entire 
follow-up;  
 
DV 3= 
cardiac 
function 
(evidence 
of 
recovery, 
no 
change, or 
progressiv
e 
dysfunctio
n) from 
Baseline 
to 3 years 
(all cases 
were 
asymptom
atic at 
baseline) 
according 
to a 
specific 
criterion 
listed. 
(ORs) and 95% 
confidence 
intervals (CIs)]  
 
Two Cox 
proportional 
hazard models 
using baseline 
data 
P VALUE 
0.023=co
mpared to 
CG 
recovery 
 
 On 3-year 
echocardi
ography at 
3 years 
[81/226 
(35.8%) 
vs. 56/225 
(24.9%), 
odds ratio 
1.44, 95% 
CI 1.08–
1.92, P = 
0.011]. 
 
At 51.0 ± 
8.2 
months 
follow-up, 
the CG = 
38/310 
(12%) 
[mean 
event-free 
survival 
1865 
days, 95% 
confidenc
e interval 
(CI) 
1817–
1913 
days] vs. 
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41/301 
(14%)  
 
IG= (1855 
days, 95% 
CI 1804–
1906 
days) 
experienc
ed the 
primary 
composite 
endpoint 
of de novo 
CHF 
hospitaliz
ation or 
all-cause 
mortality 
(P = 0.574 
 
 
CG=received standard of care 
IG=intervention group; LOS= length of stay;  
CF=cardiac function 
NIL-CHF =Nurse-led Intervention for Less Chronic Heart Failure 
 
ARTICLE 9: Veroff, D. R., Sullivan, L. A., Shoptaw, E., Venator, B., Ochoa-Arvelo, T., Baxter, J. R., & ... Wennberg, D. (2012).  Improving Self-Care for Heart Failure for 
Seniors: The Impact of Video and Written Education and Decision Aids.  Population Health Management, 15(1), 37-45 9p. doi:10.1089/pop.2011.0019 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
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Veroff et al., 
2012.  
Improving 
Self-Care for 
Heart Failure 
for Seniors: 
The Impact of 
Video and 
Written 
Education and 
Decision Aids 
 
NR RCT 
 
-
Contacte
d eligible 
CHF 
study 
patients 
by phone 
to 
complete 
a survey 
(SF-12 
Health 
Survey, 
version 
2) 
 
- 
Combine
d results 
from 
waves 1 
and 2 for 
analysis 
 
 
Eligibili
ty: CHF 
member
s in a 
Medicar
e 
Advant
age 
nonprof
it health 
plan  
 
Wave 1:  
N= 363 
IG=178 
CG=18
5 
 
Wave 2: 
N=2076 
IG=992 
CG=10
84 
 
 
Attritio
n rate: 
many 
never 
answere
d the 
telepho
ne; 25% 
of 
survey 
phone 
refused; 
RR 
IV= basic 
program 
informatio
n and a 
simple 
fact sheet 
about HF; 
plus, a 
medical 
decision 
aid, 
LWHF 
DVD and 
booklet; 
CG= the 
basic 
written 
materials 
only 
 
DV1= 
DWM 
 
DV2= SC 
 
DV3= HS 
 
DV4= 
HCCU 
 
 
Cochran-
Mantel-
Haenszel test 
=categorical 
variables.  
ANCOVA=me
dical cost 
impact.  
 
 
chi-square and 
Cochran-
Mantel-
Haenszel 
tests=P value;  
LOS= P < 
0.05. 
 
All statistical 
analyses = 
SAS, version 
9.1  
 
 
T 
test=cont
inuous 
variables 
 
 chi-
square 
test = % 
-44% of 
IG survey 
=weighed 
daily vs. 
CG= 
37%(p=0.
05) 
-  
Significan
t age- and 
comorbidi
ty-
adjusted 
rates: 
IG= 42%,  
CG= 38% 
(P=0.03) 
 
-IG=67% 
stated 
daily or 
every 
other day 
weighing 
VS. CG = 
57% 
(P=0.05). 
 
2ndary 
outcomes 
(SC, HS, 
HCCU) 
=p >0.05 
but 
favored 
IG   
 
Level = II  Strengths  
 
-DA: ↑ active participation = 
informed value based health 
decisions; 
- ↑ SCB = using DVDs, VHS tapes, or 
Internet programs that are easy and 
broad.  
-significant  ↑ in SCB may require 
more intense 
disease management approach 
  
 
Limitations: nonresponse bias:  
- ↑ response in pts under 75 vs older 
than 75 
-↑ survey response if CHF patient had 
other comorbidities vs. only CHF  
 
 
CG=nonresponse difference by 
comorbidity status 
 
IG= similar by comorbidity 
status 
 
Risk or harm if implemented: NR 
 
Feasibility of use in your practice:  
 
↑ DWM with LWHF DVD/booklet 
other important and fundamental self-
care behaviors within 
4 to 6 weeks of receiving the 
program.   
 
-↑ SCB with medical DA in this study 
- Could use this type of education  
 
 55 
 
not 
markedl
y 
differen
t by 
study 
wave or 
group 
 
 
a SCP  
HOWEVER, this type of aid should 
be used along with other intense 
disease management ↑ significant 
SCB   
DA= decision aids 
HF=heart failure  
LWHF=living with heart failure  
HCCU-health care cost and utilization 
DWM=daily weight monitoring  
SC=self-care; HS=health status  
SCP=standardized care plan 
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ARTICLE 10: Feltner, C., Jones, C., Cene, C., Zheng, Z., Sueta, C., Coker-Schwimmer, E.,…Jonas, D. (2014).  Transitional care interventions 
to prevent readmissions for people with heart failure.  Agency for Healthcare Research and Quality, 14(133), 1-238.  Retrieved from  
https://www.effectivehealthcare.ahrq.gov/ehc/products/510/1910/heart-failure-readmission-report-130527.pdf 
 
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Feltner et al., 
2014.  
Transitional 
care 
interventions 
to prevent 
readmissions 
for people with 
heart failure. 
NR SR/ MA  
 
Purpose: 
efficacy 
of TCI to 
↓ 
Readmis
sion & 
mortality 
with a 
focus on 
effective 
interventi
ons 
 
Results: 
2280 
RCTS 
from 
MEDLI
NE, 
CINAHL
; 
COCHR
ANE 
LIBRAR
Y;  
 
 
N=53 
publish
ed 
articles 
reportin
g on 47 
studies 
out 402 
eligible 
articles 
 
AR: 
349 
exclude
d: 
INELIG
IBLE: 
publicat
ion 
type: 41  
design: 
62  
populati
on:145 
NI: 30  
compar
ator: 4 
outcom
IV1=TCI  
 
DV=↓30-
day 
Readmit 
and 
mortality 
in 
hospitaliz
ed with 
HF.  
 
DV2= 
readmissi
ons 
measured 
over 3 to 6 
months  
 
DV3= 
other 
health 
care use 
(e.g., ER 
visits),  
 
DV4= 
QOL  
 
TCI- what 
intervention 
was being used 
at 30 days or 3, 
6 months 
 
30-day 
readmissions: 
Pts discharged 
and readmitted  
 
Readmissions 
(3&6 months) 
= readmissions 
that could be 
related to HF 
cause  
 
QOL= 
Minnesota 
Living with 
Health 
Failure 
Questionnaire 
(MLWHFQ) 
 
 
 
binary & 
continuo
us 
outcome
= RR & 
95% CI   
 
Weighte
d mean 
differenc
e=multip
le scales 
since 
MA 
  
 
SMD=  
Cohen’s 
d.  A 
Cohen’s 
d of zero 
= IG & 
CF 
equivale
nt effect: 
small 
effect 
size is 
0.20, 
15 RCT/ 
HV-P  
 
13 RCT/ 
STS  
 
8 
RCT/tele 
monitorin
g 
 
7 RCT/ 
OCBI 
 
4 
RCT/Prim
ary 
interventi
on   
 
2 RCT/ 
other (1 
individual 
peer 
support & 
1 
cognitive 
training 
for pts 
Level = I Strengths: 
 
 included trials w/ preserved and 
reduced EF 
 
- We did not include or exclude trials 
based on any 
specific set of components; for that 
reason, included trials assess diverse 
intervention 
 
Limitations: 
-Interventions for pts discharged 
home – unsure if benefit to dc to 
another institution such as assisted 
living.  
 
-Trials had to enroll patients during or 
soon after a hospitalization for HF 
and had to measure a readmission rate 
at or before 6 months.  
 
-did not include readmission rates or 
mortality rates post 6 months;  
interventions that we did not find 
efficacious may or may not be 
beneficial in long-term disease 
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139 
additiona
l 
resources
; 
0 gray 
literature  
Included:  
RCTs 
were 
eligible 
for all 
KQs. 
 
-
NRCT/pr
ospective 
cohort 
studies 
For CGB 
and SCB  
 
English-
/human 
only 
studies 
 
publishe
d: July 1, 
2007- 
May 9, 
2013 
Adult/inp
atient/C
HF 
patients 
es: 33 
timing: 
34 
 
mostly 
include
d trials 
with 
adults 
with 
moderat
e to 
severe 
HF. 
DV5= 
potential 
harms 
MA using 
random-effects 
models to 
estimate 
pooled effect 
 
 (NNT) for 
readmission 
and mortality 
outcomes. 
 
 
medium 
effect 
size is 
0.50, and 
large 
effect 
size is 
0.80. 32 
For 
readmissi
on rates, 
we 
conducte
d meta-
analyses 
of 
studies 
that 
reported 
the 
number 
of people 
with 
coexisting 
mild 
cognitive 
impairme
nt. 
 
 
1.  
HV-P 
(high 
SOE) 
ACR at 3 
to 6 
months: 
0.75 (0.68 
to 0.86) 
At 30 
days there 
was low 
SOE  
Over 3 to 
6 months, 
our 
meta-
analysis  
 
8 trials SD 
in ↓ risk 
of 
mortality 
among 
patients 
receiving 
home 
visits than 
among 
those 
receiving 
management in patients with HF (e.g., 
perhaps for reducing 12-month 
readmission rates). 
 
- publication bias and selective 
reporting possible  
 
- Most included trials did not use a 
readmission risk-prediction tool to 
determine 
inclusion eligibility 
-majority of pts with mod to  
severe HF based on NYHAC  
 
Risk or harm if implemented: NR 
 
Feasibility of use in your practice:  
  
 
-STS ↓ HF-specific readmission and 
mortality but NSD in  
Readmission.  
 
-HV-P and MDS-HF clinic 
interventions ↓reduced all-cause 
readmissions and mortality over 3 to 
6 months;  
 
-↓ HF-specific readmissions and 
mortality with STS 
  
NSD in tele monitoring & only EI to 
↓ readmissions or mortality 
 
-In general, interventions primarily 
delivered remotely (i.e., 
tele monitoring, STS) were not 
efficacious in ↓ all-cause readmission 
rates. 
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usual care 
(RR, 0.77; 
95% CI, 
0.60 to 
0.996). 
 
high-
intensity 
home-
visiting 
trial 
showed 
efficacy in 
reducing 
30-day 
all-cause 
readmissi
on and the 
composite 
endpoint 
but both 
low SOE 
 
 
2. STS:  
High SOE 
at 3 to 6 
months in 
7 trials 
resulted in 
0.74 (0.61 
to 0.90) 
NSD at 30 
days; and 
low 
benefit for 
composite 
endpoint 
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6 trials/SD 
↓ risk of 
mortality 
among 
patients 
receiving 
STS than 
among 
controls 
(RR, 0.69; 
95% CI, 
0.51 to 
0.92) 
 
 
3. Tele 
monitorin
g: NSD 
 
4.  
MDS-HF 
clinic: 
 
3 trials 
showed 
SD ↓ in  
mortality 
over 3 to 6 
months 
CG (RR, 
0.56; 95% 
CI, 0.34 to 
0.92) 
 
 
  
 
5.Nurse 
led clinics 
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2 trials 
NSD in 
mortality 
over 3 to 6 
months 
between 
NL clinic 
interventi
ons & 
usual care 
(RR, 
0.59; 95% 
CI, 0.12 to 
3.03; I 
2 83.8%) 
 
PCC/EI/C
T= NSD 
 
 
↑QOL=N
SD  
 
NSD to 
conclude 
if one of 
interventi
ons > than 
another  
or if 
differed 
between 
subgroups 
 
1/3 
assessing 
MDS-HF 
clinics 2/3 
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Taiwan & 
Canada. 
 
Half of 
HV-P in 
US/ and 
others in 
Australia, 
UK, & 
various 
European 
countries 
ACR= all cause readmission; CGB=care giver burden; CT= cognitive therapy; EI=educational intervention(only); EF=ejection fraction  
HVP=home visiting program; MA=meta-analysis; MDS-HFC =Multidisciplinary heart failure clinic; NSD=no significant difference; 
NYHAC=New York Heart Association classification; PCC=primary care clinic; RCT=random controlled trial; SCB=self-care burden; SMD=standard mean difference; 
SOE= strength of evidence; STS=Structured telephone support  
 
Article 11: Wakefield, B., Boren, S., Groves, P., Conn, V. (2013).  Heart failure care management programs: a review of study interventions and meta-analysis of outcomes.  
Journal of Cardiovascular Nursing, 28(1), 8–19.  doi: 10.1097/JCN.0b013e318239f9e1 
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Wakefield, B., 
Boren, S., 
Groves, P., 
Conn, V. 
(2013).  Heart 
failure care 
management 
programs: a 
review of 
study 
interventions 
and meta-
NR SR/MA 
35 
studies,  
 
8071 
total 
subjects 
in all 
studies 
Mean 
[SD] 
age, 
70.7 
[6.5] 
years) 
and 
male 
(59%) 
 IV – 
finding 
the 
various 
single 
interventi
on in 
studies 
that make 
up multi 
componen
t HF 
MEDLINE, 
CINAHL, 
Cochrane 
search using 10 
different search 
terms. 
 
 
Descripti
ve 
statistics 
for 
interventi
ons 
Meta-
analysis 
used 
standardi
zed mean 
Most 
programs 
had a 
mean of 
6.4 in the 
teaching 
componen
ts of 
specific 
recurring 
themes of 
individual
Level I Strengths  
 
-most common interventions were 
patient education, symptom 
monitoring, medication adherence 
strategies 
 
Limitations 
Limits: Fewer than half of the 35 
studies reviewed reported adequate 
data to be included in the meta-
analysis; 
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analysis of 
outcomes.  
Journal of 
Cardiovascular 
Nursing, 28(1), 
8–19.  doi: 
10.1097/JCN.0
b013e318239f
9e1 
 managem
ent 
programs 
(used a 1-
7 coding 
scheme 
for IV 
used in 
individual 
studies) 
differenc
e(d); 
effect 
size(ES); 
odds 
ratio for 
mortality 
Coded 
data: 
baseline 
and 
outcome 
sample 
size; 
means; 
variabilit
y; p 
values 
from t 
tests, and 
chi 
statistics 
 
ized 
education 
focusing 
on topics: 
symptom 
and 
medicatio
n 
managem
ent, self-
efficacy,   
 
.  
  
 
Outcomes were left out making the 
statistics invalid to detect treatment 
effects        
 
Risk or harm if implemented= NR 
 
Feasibility of use in  
your practice  
 
More research needed to be definitive 
on which intervention has largest 
impact.  
Focus on symptom recognition, 
medication review, and self-
monitoring.  
Individual interventions need to be 
described for program replication 
 
SE= self-efficacy  
RM=role modeling 
PV02= peak exercise test peak oxygen uptake 
Article 12: Wang, S.P., Lin, L.C., Lee, C.M., Wu, S.C. (2011).  Effectiveness of a self-care program in improving symptom distress and quality of life in congestive heart 
failure patients: a preliminary study.  J Nurs Res. 19(4), 257-66.  doi: 10.1097/JNR.0b013e318237f08d. 
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
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Wang, S.P., 
Lin, L.C., Lee, 
C.M., Wu, 
S.C. (2011). 
NR RCT  N=27 
(control 
13 / 
interven
tion = 
14) 
Comple
tion 
rate: 
87% 
Mean 
age= 
72.43 
+10.25 
years 
and 
70.46 + 
11.83 
years 
Mostly 
men 
Rando
mized 
pts from 
2 
cardiac 
units at 
1 
Taiwan 
hospital 
4 
IV= 
HFSC 
course 
 
 
CG= usual 
care 
DV: 
symptoms
, 
functional 
status, 
quality of 
life, 
reduced 
hospital 
and 
emergenc
y room 
readmissi
on rates  
 Symptom 
distress 
Questionnaire 
 
SMWT  
 
Quality of Life 
Questionnaire 
(SF036 Taiwan 
Version) 
Unplanned 
readmission 
data via health 
record 
 
SPSS for 
windows 
version 
11 
 
Characte
ristics: 
frequenci
es, 
percenta
ge, chi 
square, t 
tests.  
Differenc
e in pre- 
and post-
interventi
on 
groups in 
SDQ, 
SMWT, 
and SF-
36= non- 
parametri
c mannn-
whitney 
U test.  
 
3-month 
SD in 
HFSC vs. 
CG:  
symptom 
distress (p 
< .01) 
 
6-minute 
walk test 
results (p 
< .01) 
 
QOL 
(using 
Short 
Form 36, 
Taiwan 
version, p 
< .05 
 
NSD 
hospital 
readmissi
on and ED 
visits 
 Level II Strengths  
there is a benefit in management 
program for HF which may ↑ 
mortality and other outcomes  
Limitations: only 3-month follow-up 
time.  Small sample size so cannot be 
generalized to all heart failure 
patients; the generalizability is limited 
due to the one hospital site.  
 
Risks: NR 
Feasibility for use in your practice: 
expand the sample size, number of 
facilities, and lengthen follow up 
beyond 3-month reassessment  
Further research needed to ↑SC 
education and impact on HF 
Readmission or ED visits 
  
- 
Lack of ongoing FU after discharge 
makes evaluation and disease 
management difficult. 
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Article 13: Koberich, S., Lohrmann, C., Mittag, O., & Dassen, T. (2015).  Effects of a hospital-based education program on self-care behavior, care dependency and quality of 
life in patients with heart failure - a randomized controlled trial.  Journal of Clinical Nursing, 24(11/12), 1643-1655 13p. doi:10.1111/jocn.12766 
 
Citation Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables  
Measurement 
of Major 
Variables 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of Evidence: 
Koberich, S., 
Lohrmann, C., 
Mittag, O., & 
Dassen, T. 
(2015).  
Effects of a 
hospital-based 
education 
program on 
self-care 
behavior, care 
dependency 
and quality of 
life in patients 
with heart 
failure - a 
randomized 
controlled trial.  
Journal of 
Clinical 
Nursing, 
24(11/12), 
1643-1655 
13p. 
doi:10.1111/jo
cn.12766 
NR Nonblind
ed, 
prospecti
ve single 
center, 
RCT 
N=11ce
nter 58; 
CG= 
52) 
62 = 
mean 
age; 
mean 
left 
ventricu
lar 
ejection 
fraction 
of 
28·2% 
nurse-
led, 
inpatien
t HF EI 
with 3-
month 
phone 
call 
follow 
up on 
SCB & 
CD, and 
QOL   
IV group= 
education 
about HF 
self-care 
with 
telephone 
f/u over 3 
months in 
addition to 
standard 
treatment. 
Control 
group= 
standard 
medical 
treatment 
only 
 Self-care 
behavior 
measured with 
G9-EHFScBS 
(scores range 
9-45; lower 
scores=better 
self-care) 
Care 
dependency 
measured=CD
S- (Virginia 
Henderson 
nursing theory 
basis; scores 
range 15-75 
with lower is 
higher CD) 
 
HF quality of 
life= KCCQ.  
(0-100 scale, 
higher 
indicates better 
health) 
Question
naires 
during 
hospital 
stay or 
outpatien
t clinic 
after 
informed 
consent. 
 
IBM 
SPSS 
statistics, 
version 
19.  
-Missing 
values 
were 
assigned 
the mean 
within 
that 
section 
 
Descripti
ve 
statistics 
for 
patient 
SCB for 
IVG= 
P<0.001  
 
Non-
significant
(p=0.15) 
in the CG 
 
Interventi
on only 
had 
P<0.00 for 
weighing  
 
QOL= 
improved 
in both 
IVG and 
CG  
 
CG= only 
had self-
efficacy to 
improve 
with a 
P<0.001 
 
CD= non- 
changes 
between 
Level = II Strengths  
Single phone  
follow up ↑ SCB 
 but NSD in QOL or CD.  
 
 
Limitations: 
-excluded patients with ICD or CRT 
in last 3 months 
-single study site 
- + effects of education could alter 
investigators expectation.  
- Bias for socially desired answers 
due to timing: Telephone 1 
intervention=completed after 
telephone call 
 
 
Risk or harm if 
 implemented= NR 
 
Feasibility of use in  
your practice  
Single phone follow up ↑  
SCB but NSD in QOL or CD.  
 
To improve QOL OR CD  
you will need further research 
measures   
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 character
istics 
 
Changes 
in SC, 
CD, and 
QOL = 
mixed 
ANOVA 
with 
repeated 
measures 
 
Statistica
l 
significa
nce= p< 
<0.05   
IVG and 
CG  
 
 
CDS=care dependency scale 
G9-EHFScBS=German version of nine-item European Heart Failure Self-care Behavior Scale 
KCCQ=Kansas City Cardiomyopathy Questionnaire 
SE= self-efficacy  
RM=role modeling 
PV02= peak exercise test peak oxygen uptake 
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Appendix C 
 American Heart Association Telephone Intervention  
 
GENERAL INFORMATION 
Discharge date: 
(mm/dd/yyyy)  
 
Patient name:   
Date of birth:  
(mm/dd/yyyy) 
 
Primary care physician:    
Cardiologist:   
Homecare?     YES   NO 
Labs ordered/done prior to first follow-up call 
or appointment? 
  YES   NO 
Date:  
(mm/dd/yyyy) 
 
PATIENT EDUCATION 
INTRODUCTION: My name is _______________________.  I am calling from [INSERT HOSPITAL NAME].  
I am doing a follow-up courtesy call to see how you are doing. 
Weight monitoring  
Do you have a scale at home that you can use 
to weigh yourself?   
  YES   NO 
If no: Comments__________________________ 
[If patient answered no, advised the patient to 
buy a scale] 
  YES   NO 
 
[If patient answered yes to having a scale] 
Can you see the numbers on the scale?   
  YES   NO 
Have you been weighing yourself daily?   YES   NO 
Dry weight (at home,1st day after discharge)  
Did you take your dry weight 1 day after 
discharge?   
  YES   NO 
 
Do you have a weight diary?     YES   NO 
If no, was the patient 
provided with a weight 
calendar during this visit?   
  YES   NO 
Do you understand how and when to check your 
weight?  
[Tell patient that he/she should check weight 
every AM, after first void, prior to PO intake; 
with same amount of clothing on] 
  YES   NO 
 
Do you understand the importance of measuring 
and recording your daily weights?  
[Tell patient that daily weights are important to 
self-monitor for fluid retention]  
  YES   NO 
 
Confirmed understanding by Teach Back?  Yes 
  Patient needs reinforcement   
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[The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding] 
Comments: 
Fluid restriction (if applicable to this patient)  
Do you know why it is important to restrict 
your fluid intake?   
  YES   NO 
 
How many liters of fluid do you consume a 
day? 
 
[Tell patient that he/she should keep fluid intake 
to less than 2 L/day of fluid a day to lessen 
congestion and decrease the need for diuretics.] 
 1.5 L  
 2.0 L  
 N/A    
 
Confirmed understanding by Teach Back? 
The patient or family member can verbalize 
your instructions back to you in their own 
words to confirm understanding. 
 Yes 
  Patient needs reinforcement   
Comments: 
Low-sodium diet  
Are you following a low-sodium diet?  If yes, 
what is your sodium limit per day?    
  YES      NO (reason): 
______________________________________ 
Review low-sodium diet expectations in 
relation to patient’s individual scenario (i.e., 
eats out, likes ethnic foods, is thirsty, uses salt 
when cooking, reads labels, someone else 
cooks, etc.). 
 
  YES   NO 
 
Confirmed understanding by Teach Back? 
[The patient or family member can verbalize 
your instructions back to you in their own 
words to confirm understanding]. 
 Yes 
  Patient needs reinforcement   
Comments: 
Exercise  
Are you engaging in daily physical activity?  
  
  YES      NO (reason): 
______________________________________ 
Review importance of exercise for heart failure 
patients 
 
  YES   NO 
 
Habits  
Are you currently a smoker?  
[a smoker is defined as someone who has 
smoked anytime in the past year] 
 
  YES   NO 
 
If patient answers yes, did you provide the 
patient with smoking-cessation counseling?   
  YES   NO 
Do you consume alcohol?  
[patients with heart failure should be advised 
not to consume alcohol] 
  YES   NO 
Do you take any illicit drugs?     YES   NO 
 
Confirmed understanding by Teach Back? 
[The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding] 
 Yes 
  Patient needs reinforcement   
Comments: 
 
Signs and symptoms  
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List the ways you know your heart failure is 
getting worse?  
If the signs or symptoms (above) get worse, what 
will you do?  Whom will you call?  
 
 
 
  YES   NO 
 
[Review with patient the contact information for 
whom to call in case they experience signs of 
symptoms of heart failure?] 
PCP name:  
Phone number: 
Phone number:  
Cardiologist:  
Phone number:  
NP:  
NP number:  
Weight/swelling  
Do you know what do if you gain more than 2 
pounds in 1 day or 5 pounds in a week?   
[Tell the patient that he/she should contact his/her 
physician if he/she gains excessive weight] 
  YES   NO 
 
Do you know what to do if you notice more swelling 
in the feet, ankles, or stomach region?  Or if you 
wake up suddenly from a sound sleep or are urinating 
at night (more than previously)? 
[Tell the patient that he/she should contact his/her 
physician if he/she gains excessive weight] 
  YES   NO 
 
Confirmed understanding by Teach Back? 
[The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding] 
 Yes 
  Patient needs reinforcement   
Comments: 
Breathing   
Have you experienced worsening in shortness of 
breath?   
  YES   NO 
If yes, when: _________________________ 
[Review with patient what do if they experience the 
below  
-More shortness of breath than usual  
-It is harder to breathe when lying down  
-If you develop dry hacking cough] 
Review provided.   
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Other symptoms  
[Review with patient what to do if they are feeling 
more tired/have less energy, have a poor appetite/or 
early satiety, or are feeling uneasy; or “something is 
not right”] 
  Completed 
 
Pt should go the emergency room/call 911 if:  
[Explain to patient that they should go to emergency 
room or call 911 if they experience any of the below 
symptoms: 
-struggle to breathe or have unrelieved shortness of 
breath while at rest 
-chest pain 
- new or worsening confusion or having trouble 
thinking clearly 
  Completed 
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- persistent palpitations (racing heart) 
- lightheadedness that does not quick resolve 
- passing out] 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
______________________________________ 
Medications for Heart Failure Management   
Medication Reconciliation Completed  Comments:  
 
Can you afford to buy your medications? 
 
  YES   NO (reason): 
_________________________________ 
Have you filled your prescription(s) as 
ordered?    
  YES   NO (reason): 
_________________________________ 
Do you have a prescription drug plan? 
 
  YES   NO (reason): 
_________________________________ 
Diuretic  
(if applicable to this patient) 
Are you taking a diuretic?     YES   NO 
[Provide the patient education regarding the 
use/indication for this drug: water pill to 
remove excess water from legs, feet, lungs and 
stomach] 
 Patient Education Provided 
 Patient education not provide due to medical 
contraindications to diuretic 
If patient is not on diuretics indicate why 
(contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
[The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
ACE-inhibitor or angiotensin receptor blocker If patient has reduced LVEF (LVEF <40%) 
(if applicable to this patient) 
Are you taking an ACEI or ARB?   YES   NO 
 [Provide the patient with education on how 
ACEI or ARBs can serve to relax blood vessels, 
making it easier for heart to pump, can lower 
blood pressure] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to ACEI or ARB 
If patient is not on ACEI or ARB indicate why 
(contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Beta-blocker if patient has reduced LVEF (LVEF<40%) 
(if applicable to this patient) 
Are you taking a beta blocker?  
[If pt has reduced LVEF (EF < 40%) preferred 
evidence-based beta blockers are carvedilol, 
metoprolol succinate (XL) and bisoprolol] 
  YES   NO 
[Provide the patient with education on how a 
beta blocker can help the heart pump better 
over time and can block the body’s response to 
certain substances that damage heart muscle] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to beta blocker 
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If patient is not on beta blocker, indicate why 
(contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Aldosterone antagonist if patient has reduced LVEF (LVEF<40%) 
(if applicable to this patient) 
Are you taking an aldosterone antagonist?  
[If pt has reduced LVEF (EF < 40%) need to 
closely monitor K and Cr] 
  YES   NO 
[Provide the patient with education on how 
aldosterone antagonist helps to block sodium 
and water reabsorption, helps prevent further 
damage to heart, and that at low doses, 6.25-25 
mg/day, is not used as a water pill.] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to aldosterone antagonist 
If patient is not on aldosterone antagonist, 
indicate why (contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Hydralazine/ nitrate for African American patients with reduced LVEF (EF < 40%) 
(if applicable to this patient) 
Are you taking hydralazine/nitrate (if pt has 
reduced LVEF and is of black race)  
  YES   NO 
[Provide the patient with education on how 
hydralazine/nitrate can help open the vessels of 
the heart and makes it easier for the heart to 
pump.] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to hydralazine/nitrate 
If patient is not on hydralazine/nitrate, indicate 
why (contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Warfarin or other anticoagulant (If indicated for patients with chronic/recurrent afib or mechanical valve) 
Are you taking warfarin or other oral 
anticoagulant?  
  YES   NO 
[Provide the patient with education on how 
warfarin or other anticoagulant can help to 
prevent stroke by serving as blood thinner.] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to warfarin or other anticoagulant 
If patient is not on warfarin or other 
anticoagulant, indicate why 
(contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
[The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Potassium/magnesium supplements 
(if applicable to this patient) 
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Are you taking potassium/magnesium 
supplements? 
  YES   NO 
[Provide the patient with education on how 
potassium/magnesium supplements can help to 
replace important electrolytes that are lost 
when the patient urinates due to taking water 
pills.] 
 Patient education provided 
 Patient education not provide due to medical 
contraindications to potassium/magnesium supplements 
If patient is not on potassium/magnesium 
supplements, indicate why (contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Lipid-lowering medication if pt has CVD, PVA or CVA 
(if applicable to this patient) 
Are you taking lipid-lowering medications?    YES   NO 
If patient is not on lipid-lowering medication 
indicate why (contraindications). 
Patient had side effects that include:  
 
 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Omega 3 fatty acid supplementation 
(if applicable to this patient) 
Are you taking omega 3 fatty acids?    YES   NO 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
Diuretic self-management 
Is the patient an appropriate candidate for 
diuretic self-management? 
  YES   NO 
[Reviewed when it is appropriate to take extra 
diuretics +/- potassium based on weight gain]  
  YES   NO 
[If weight gain persists > 2 days, advised the 
patient to call MD/ NP] 
  YES   NO 
Confirmed understanding by Teach Back? 
 [The pt or family member can verbalize your 
instructions back to you in their own words to 
confirm understanding.] 
 Yes 
  Patient needs reinforcement   
Comments: 
 
Other questions   
Have you scheduled a follow-up appointment?   YES   NO 
Comments:  
Do you have access to transportation to and from the 
hospital? 
  YES   NO 
Comments: 
Do you have any other questions related to?   diet  activity  medications  
other concerns (list): ________________ 
GENERAL INFORMATION:  
General comments   
 
 
Further action needed post follow-up call?     YES   NO 
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If yes, what follow-up action is 
needed/performed?   
 Notify Dr, 
 
Name: 
Number:  
Date 
Time 
 call in 
prescriptions to 
pharmacy  
 
Pharmacy name: 
 
Pharmacy phone number: 
 call patient regarding_____________________________ 
Set up 
appointment 
with Dr.  
Dr. name  
Call in [  ] days for:  
Other:   
Telephone:  Person interviewed:  Patient   
Other (name/relation): 
__________________________________ 
 
Attempts to contact:   
Date:  Time:  Initials: 
Date:  Time:  Initials: 
Date:  Time:  Initials: 
RN name (print):  
Rn signature:  
Date: Time: 
 
 
 
TEMPLATE TELEPHONE FOLLOW-UP 
INTERVIEWER INSTRUCTIONS 
COMPLETE FOLLOW-UP FORM (See below). 
 
ITEMS REQUIRING FURTHER INTERVENTION: 
 
CONTACT PHYSICIAN FOR: 
01 Unfilled prescriptions 
02 Questions on medications 
 
CONTACT SCHEDULER FOR: 
01 Follow-up appointment 
 
CONTACT NURSE FOR: 
01 Questions on diet, activity 
02 Further evaluation of worsening symptoms 
03 Follow-up on weight monitoring 
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Appendix D 
Atlanta Heart Failure Knowledge Scale(AFHKS) Tool 
 
 
(Reilly et al., 2009) answers indicated with *asterisk 
We have some questions about heart failure.  Select one response for each question. Don't worry if you are not sure 
of the answers; just do the best you can. 
 
1. Heart failure is a problem in which: 
 
a. There is too much blood in the body 
b. The heart is unable to pump enough blood * 
c. The blood vessels in the heart are clogged 
d. The heart skips beats 
 
2. Which of the following statements about heart failure is TRUE? 
 
a. It can be cured with drugs and other treatments. 
b. A person with heart failure cannot live a normal life 
c. Heart failure cannot be cured but it can be controlled.  * 
d. Heart failure means the heart has stopped beating. 
 
People with heart failure can do many things to help themselves.  Think about each of these 
activities and decide if they would be helpful for someone with heart failure:  YES OR NO:  
 
3. Avoid salty foods?  * YES OR NO 
4. Drink lots of fluids?  YES OR NO* 
5. Stop smoking?  * YES OR NO 
6. Drink alcoholic drinks each day to relax?  YES OR NO* 
7. Skip heart failure medicines when they feel better?  YES OR NO* 
8. Know when to call the doctor or nurse for symptoms of heart failure?  YES* OR NO 
 
9. ACE inhibitors (ex. Capoten, Vasotec, Lisinopril, or Zestril) are medicines used to treat heart 
failure.  These drugs help the heart pump stronger by: 
 
a. Removing extra fluid and salt from the body 
b. Causing blood vessels to get smaller 
c. Blocking the harmful effects of stress hormones* 
d. Improving blood counts (reducing anemia) 
 
10. People who have heart failure take diuretics (Lasix, "water pills") so that: 
 
a. Their kidneys will make more urine and pass more water* 
b. Their heart will beat more steady 
c. The blood vessels in their body will widen or relax 
d. Their heart will pump stronger 
 
11. People with heart failure who are taking a diuretic (“water pill”) need to: 
 
a. Know if they need to take extra potassium with their water pill* 
b. Take the diuretic after 3-4 pm in the day 
c. Not worry about signs and symptoms of dehydration 
d. Drink lots of water to replace lost fluid 
12. If a person with heart failure gains 2-3 pounds in a few days, this usually means he/she: 
 74 
 
a. Is eating too many calories and gaining weight 
b. Has extra water in the body* 
c. Needs to drink more fluid 
d. Needs to be getting more exercise to burn calories 
 
13. How often should a person with heart failure weigh themselves? 
 
a. Every day* 
b. Every week 
c. Every month 
d. Once in a while 
 
14. The best time of day for persons with heart failure to weigh themselves is: 
 
a. At bedtime 
b. Upon awakening in the morning* 
c. At or around lunchtime 
d. When they remember to do it 
 
15. Persons with heart failure should call their doctor if they have which of the following 
symptoms? 
 
a. Weight gain of 2-5 pounds in 1-2 days 
b. Increased swelling of the ankles and/or stomach 
c. More shortness of breath 
d. All the above* 
16. How often should a person with heart failure exercise? 
 
a. Every week 
b. Every day* 
c. Several times a day 
d. 2-3 times per week 
 
17. A person with heart failure should stop and rest when doing physical activity if: 
 
a. They feel short of breath or winded 
b. They have chest pain or discomfort 
c. They feel dizzy or lightheaded 
d. All the above* 
 
18. Which is a big source of sodium (salt) in the diet? 
 
a. Processed foods (such as tv dinners) 
b. Smoked or cured meats 
c. Table salt 
d. All the above* 
 
19. Which has the LOWEST amount of sodium (salt)? 
 
a. Fresh fruits* 
b. Canned vegetables 
c. Reduced sodium soup 
d. Frozen dinners 
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20. Which food has the MOST sodium (salt)? 
 
a. Sliced tomato 
b. Broiled fish 
c. Baked ham* 
d. Skim milk 
 
21. Which dessert has the LOWEST amount of sodium? 
 
a. Hot fudge sundae 
b. Baked apple* 
c. Low fat instant pudding made with skim milk 
d. Chocolate cake made from a mix 
 
22. Select the fast food with the LOWEST amount of sodium. 
 
a. Fried chicken 
b. Cheeseburger 
c. Baked potato with sour cream and chives* 
d. Taco salad 
 
23. Some people with heart failure are told by their doctor to limit fluids. Which of the following 
count as fluids? 
 
a. Water and clear liquids 
b. Milk, ice cream, and yogurt 
c. Jell-O, pudding, and soups 
d. All the above* 
 
24. If a person with heart failure has a headache or pain, which would be the best medicine to 
take? 
 
a. Aspirin 
b. Tylenol (Acetaminophen)* 
c. Advil® or Motrin® (Ibuprofen) 
d. Anacin Regular Strength or Excedrin 
 
25. The recommended total daily amount of sodium that persons with heart failure should eat is: 
 
a. 3,000 milligrams 
b. 2,500 milligrams 
c. 2,000 milligrams* 
d. 500 milligrams 
*original question 26 & 27 removed due to not being able to ask about an image over the telephone follow-up at 30 
and 60 days. 
 
26. A person with heart failure who is trying to limit their fluids may reduce symptoms of thirst 
by: 
 
a. Chewing gum or sucking hard candy* 
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b. Cutting back on their medications 
c. Drinking small amounts every 30-60 minutes to prevent thirst 
d. Warming fluids before drinking 
 
27. If a person with heart failure forgets to take their medicine, they should: 
 
a. Take their medicines as usual the next day 
b. Take the medicines as soon as remembered* 
c. Take double the dose the next day 
d. Call their doctor immediately 
 
28. It is important for a person with heart failure to:  
 
a. Make sure they get the flu shot every year 
b. Receive the pneumovax vaccination to prevent pneumonia 
c. See their heart failure doctor regularly 
d. All the above* 
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Appendix E 
Self-Care of Heart Failure Index(SCHFI) Tool 
 
 All answers are confidential. 
Think about how you have been feeling in the last month or since we last spoke as you complete these items(Riegel, 
2009).  
SECTION A: 
Listed below are common instructions given to persons with heart failure.  How routinely do you do the following? 
 
 Never or 
rarely 
Sometimes Frequently Always or 
daily 
1. Weigh yourself? 1 2 3 4 
2. Check your ankles for swelling? 1 2 3 4 
3. Try to avoid getting sick (e.g., flu shot, 
avoid ill people)? 
1 2 3 4 
4. Do some physical activity? 1 2 3 4 
5. Keep doctor or nurse appointments? 1 2 3 4 
6. Eat a low salt diet? 1 2 3 4 
7. Exercise for 30 minutes? 1 2 3 4 
8. Forget to take one of your medicines? 1 2 3 4 
9. Ask for low salt items when eating out or 
visiting others? 
1 2 3 4 
10. Use a system (pill box, reminders) to 
help you remember your medicines? 
1 2 3 4 
 
SECTION B: 
Many patients have symptoms due to their heart failure.  Trouble breathing and ankle swelling are common 
symptoms of heart failure.  
 
In the past month, have you had trouble breathing or ankle swelling?  Circle one. 
0) No 
1) Yes 
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11. If you had trouble breathing or ankle swelling in the past month…  
  (circle one number) 
 Have not 
had these 
I did not 
recognize it 
Not 
Quickly 
Somewhat 
Quickly 
Quickly Very 
Quickly 
How quickly did you recognize it 
as a symptom of heart failure? N/A 0 1 2 3 4 
 
 
Listed below are remedies that people with heart failure use.  If you have trouble breathing or ankle swelling, how 
likely are you to try one of these remedies? 
 
 
(circle one number for each remedy) 
 Not Likely Somewhat 
Likely 
Likely Very Likely 
12. Reduce the salt in your diet 1 2 3 4 
13. Reduce your fluid intake 1 2 3 4 
14. Take an extra water pill 1 2 3 4 
15. Call your doctor or nurse for guidance 1 2 3 4 
 
16. Think of a remedy you tried the last time you had trouble breathing or ankle swelling,  
 
(circle one number) 
 I did not try 
anything 
Not Sure Somewhat 
Sure 
Sure Very Sure 
How sure were you that the 
remedy helped or did not help? 0 1 2 3 4 
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SECTION C:  
In general, how confident are you that you can:  
 Not 
Confident 
Somewhat 
Confident 
Very 
Confident 
Extremely 
Confident 
17. Keep yourself free of heart failure 
symptoms? 1 2 3 4 
18. Follow the treatment advice you have 
been given? 1 2 3 4 
19. Evaluate the importance of your 
symptoms? 1 2 3 4 
20. Recognize changes in your health if they 
occur? 
1 2 3 4 
21. Do something that will relieve your 
symptoms? 
1 2 3 4 
22. Evaluate how well a remedy works? 1 2 3 4 
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Appendix F 
Informed Consent 
The Effect of an American Heart Association Telephone Follow-Up Intervention on Knowledge and Self-
Efficacy in Rural Heart Failure Patients 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH? 
You are being invited to take part in a research study about improving heart failure knowledge and self-care.  You 
are being invited to take part in this research study because you are newly diagnosed with either mild to severe heart 
failure.  If you volunteer to take part in this study, you will be one of about 25-30 people to do so at Baptist 
Madisonville.  Nationally, the research community is working to improve heart failure outcomes.  
 
 
WHO IS DOING THE STUDY? 
 
The person in charge of this study is Haley Fuller, Doctorate of Nursing Practice (DNP) student of University of 
Kentucky, Department of Nursing.  She is being guided in this research by Dr. Melanie Hardin Pierce, University of 
Kentucky Professor; Dr. Steven Heatherly, Medical Doctor; Brenda Stephens, Advanced Practice Registered Nurse.  
There may be other people on the research team assisting at different times during the study. 
  
 
WHAT IS THE PURPOSE OF THIS STUDY? 
 
By doing this study, we hope to learn if a telephone intervention will improve self-care and knowledge to improve 
heart failure patient outcomes.  The overall results of this study will be shared with main investigators and the 
supporting University of Kentucky advisory team and the research community.  
 
 
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY? 
 
You should not participate in this study if you are less than 18 years old, prisoner, ward of the state, pregnant, or 
mentally incapacitated.  
WHERE IS, THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?  
The research procedures will be conducted at Baptist Health Madisonville Cardiology Clinic.  You will need to 
come to your normal appointments.  The study will start today at your first appointment; you will be given a consent 
and two questionnaires to answer.  You will then receive a phone call from the primary investigator, Haley Fuller, 
within the next 7 days and will be asked follow up questions from the American Heart Association.  There will be 2 
other follow up phone calls over the next 60 days. The phone calls will take approximately 10-15 minutes unless 
patient wants to add further discussion.  
 
WHAT WILL YOU BE ASKED TO DO? 
First, I am asking you to participate in two surveys today in your first office visit before your provider gives you 
heart failure education. These surveys will give us a baseline knowledge and self-engagement score to use in our 
research. 
Secondly, you or a family member on your behalf are asked to answer a telephone call within 7 days from this office 
visit to answer an American Heart Association follow up questionnaire and reinforce education you received today. 
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Thirdly, you or a family member on your behalf, are asked to participate in two other phone calls over next 60 days 
where you will be asked again two surveys. 
The overall goal is to research the education process currently used with an additional telephone education follow 
up.  The study goal is assessing the impact of self-care and knowledge on transitioning you home and to reduce heart 
failure complications.   
 
 
 
 
 
 
 
 
 
 
 
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
• There are no obvious risks except a portion of your time to take the two short in office surveys today, a 
telephone call in 1 week for a follow up lasting approximately 10 minutes’ worth of questions, and 
approximately 10 minutes’ worth of questions at each follow up telephone call in 30 days and 60 days.  
• There are no medical devices, drugs, or experimental procedures. 
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
There is no guarantee that you will get any benefit from taking part in this study.  However, research has shown a 
benefit with improved knowledge, symptom recognition, and self-care behaviors when you engage in a multi-
component heart failure education and management.  Your willingness to take part, however, may, in the future, 
help doctors better understand and/or treat others who have your condition. 
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be out of free will to volunteer.  You will not lose any benefits or 
rights you would normally have if you choose not to volunteer.  You can stop at any time during the study and keep 
the benefits and rights you had before volunteering.  If you decide not to take part in this study, your decision will 
have no effect on the quality of medical care you receive.  
 
Today:
two surveys in office 
before heart failure 
education
7 days later:
Telephone call follow up 
questionnaire and 
reinforce office visit 
at 30 days:
Repeat self-care and 
knowledge survey
At 60 days:
Repeat self-care and 
knowledge survey
Figure 1: Patient Participation Timeline 
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IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES? 
If you do not want to take part in the study, the other choice is to receive the normal in office quality standard 
education.  You will just not be receiving the additional follow up intervention. 
WHAT WILL IT COST YOU TO PARTICIPATE? 
You and/or your insurance company, Medicare or Medicaid will be responsible for the costs of all care and 
treatment you receive during this study that you would normally receive for your condition.  These are costs that are 
considered medically reasonable and necessary and will be part of the care you receive if you do not take part in this 
study. 
The University of Kentucky may not be allowed to bill your insurance company, Medicare or Medicaid for the 
medical procedures done strictly for research.  
 
Therefore, there are no additional financial costs related to participating in this study except your telephone 
use on the above mentioned 3 telephone calls with the primary investigator, Haley Fuller. 
 
WHO WILL SEE THE INFORMATION THAT YOU GIVE?    
We will make every effort to keep confidential all research records that identify you to the extent allowed by law. 
Your information will be combined with information from other people taking part in the study.  When we write 
about the study to share it with other researchers, we will write about the combined information we have gathered.  
You will not be personally identified in these written materials.  We may publish the results of this study; however, 
we will keep your name and other identifying information private.  
We will make every effort to prevent anyone who is not on the research team from knowing that you gave us 
information, or what that information is. 
Description of procedures: All private health information will be collected by Brenda Stephens APRN or Brandi 
Scott APRN.  The primary investigator, myself, is a Baptist Health employee and will keep all health information 
private.  The primary investigator will have access to patient records through the electronic medical record, EPIC.  
Epic is secured with encryption and firewall protection.  You will have a unique de-identified study number stored 
in a secure file cabinet with a lock and password protected external drive in Brenda Stephens’s office.  The research 
does not assess incidental findings that would be shared with the patient given the nature of the education. 
You should know, however, that there are some circumstances in which we may have to show your information to 
other people such as Dr. Steven Heatherly, Brenda Stephens, Brandi Scott, Baptist Institutional Review Board 
committee, UK clinical advisor.  For example, the law may require us to show your information to a court or to tell 
authorities if you report information about a child being abused or if you pose a danger to yourself or someone else.  
Officials of the University of Kentucky may look at or copy pertinent portions of records that identify you. 
 
A statistician may look at the study participant data that corresponds with an assigned number instead of patient 
name to analyze results of study. 
 
CAN YOUR TAKING PART IN THE STUDY END EARLY? 
If you decide to take part in the study you still have the right to decide at any time that you no longer want to 
continue.  You will not be treated differently if you decide to stop taking part in the study. 
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ARE YOU PARTICIPATING OR CAN YOU PARTICIPATE IN ANOTHER RESEARCH STUDY AT 
THE SAME TIME AS PARTICIPATING IN THIS ONE? 
You may not take part in this study if you are currently involved in another heart failure research study that could 
impact the results of this research.  It is important to let the investigator/your doctor know if you are in another 
research study.  You should also discuss with the investigator before you agree to participate in another research 
study while you are enrolled in this study.  
WHAT HAPPENS IF YOU GET HURT OR SICK DURING THE STUDY? 
If you believe you are hurt or if you get sick because of something that is due to the study, you should call the 
primary investigator, Haley Fuller at 270-339-6003.  If you have questions about your medical care or results during 
any of the three telephone calls you can ask for information already given to you to be reinforced but I cannot 
provide any new medical diagnosis or information.  I will refer any concerns outside the scope of this research to 
your provider as appropriate.  If you have any question about the study you may also contact Marsha Hightower 
with the Baptist Health Madisonville Institutional Review Board at 270-824-3735.   
 
It is important for you to understand that Baptist Health Madisonville or the University of Kentucky does not have 
funds set aside to pay for the cost of any care or treatment that might be necessary because you get hurt or sick 
during taking part in this study.  Also, the University of Kentucky will not pay for any wages you may lose if you 
are harmed by this study.   
 
The medical costs related to your care and treatment because of research related harm will be your responsibility.  
 
You do not give up your legal rights by signing this form. 
 
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
 
You will not receive any rewards or payment for taking part in the study. 
 
  WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS? 
 
Before you decide whether to accept this invitation to take part in the study, please ask any questions that might 
come to mind now.  Later, if you have questions, suggestions, concerns, or complaints about the study, you can 
contact the investigator, Haley Fuller at 270-339-6003.  If you have any questions about your rights as a volunteer in 
this research you may contact the Baptist Health Institutional Review Board at 270-824-3735.  
 
If you would like any further information you may contact the staff in the Office of Research Integrity at the 
University of Kentucky between the business hours of 8am and 5pm EST, Mon-Fri at 859-257-9428 or toll free at 1-
866-400-9428.  We will give you a signed copy of this consent form to take with you. 
 
WHAT IF NEW INFORMATION IS LEARNED DURING THE STUDY THAT MIGHT AFFECT YOUR 
DECISION TO PARTICIPATE? 
 
If the researcher learns of new information regarding this study, and it might change your willingness to stay in this 
study, the information will be provided to you.  You may be asked to sign a new informed consent form if the 
information is provided to you after you have joined the study.  
 
WHAT ELSE DO YOU NEED TO KNOW? 
There is a possibility that the data/tissue/specimens/blood collected from you may be shared with other investigators 
in the future.  If that is the case, the data/tissue/specimen/blood will not contain information that can identify you 
unless you give your consent/authorization or the UK Institutional Review Board (IRB) approves the research.   
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The IRB is a committee that reviews ethical issues, per federal, state and local regulations on research with human 
subjects; to make sure the study complies with these before approval of a research study is issued. 
 
AUTHORIZATION TO USE OR DISCLOSE YOUR IDENTIFIABLE HEALTH INFORMATION  
 
The privacy law, HIPAA (Health Insurance Portability and Accountability Act), requires researchers to protect your 
health information.  The following sections of the form describe how researchers may use your health information.   
 
Your health information that may be accessed, used and/or released includes: 
 
• demographic information, results of physical exams, blood tests, X-rays, and other diagnostic and 
medical procedures as well as medical history.   
 
The Researchers may use and share your health information with: 
 
• The University of Kentucky’s Institutional Review Board/Office of Research Integrity. 
• Law enforcement agencies when required by law. 
• University of Kentucky representatives. 
• Baptist Health Madisonville Institutional Review Board/ Office of Research Integrity. 
• Dr. Steven Heatherly, cardiologist.  
• Brenda Stephens, APRN. 
• Brandi Scott, APRN. 
• If needed, I will direct you to your primary provider or the cardiology provider as indicated for 
conditions needing immediate attention or questions outside the scope of this research.  
 
 
The researchers agree to only share your health information with the people listed in this document.   
Should your health information be released to anyone that is not regulated by the privacy law, your health 
information may be shared with others without your permission; however, the use of your health information would 
still be regulated by applicable federal and state laws.  
 
You may not be allowed to participate in the research study if you do not sign this form.   If you decide not to sign 
the form, it will not affect your: 
• Current or future healthcare at Baptist Health Madisonville or the University of Kentucky  
• Current or future payments at Baptist Health Madisonville or the University of Kentucky  
 
After signing the form, you can change your mind and NOT let the researcher(s) collect or release your 
health information (revoke the Authorization).  If you revoke the authorization: 
 
• You will send a written letter to: (name and contact information) to inform Haley Fuller of your decision at 
270-339-6003. 
• Researchers may use and release your health information already collected for this research study. 
• Your protected health information may still be used and released should you have a bad reaction (adverse 
event). 
 
 You understand that you will not be allowed to review the information collected for this research study until after 
the study is completed.  When the study is over, you will have the right to access the information. 
The use and sharing of your information has no time limit.  
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If you have not already received a copy of the Privacy Notice, you may request one.  If you have any questions 
about your privacy rights, you should contact the Baptist Health Privacy Officer at (270)-825-5629.    
 
You are the subject or are authorized to act on behalf of the subject.  You have read this information, and 
you will receive a copy of this form after it is signed. 
 
 
 
_________________________________                                  ____________________________ 
Signature of research subject (if applicable :)                 Date 
or *research subject’s legal representative     
 
 
_________________________________   __________________________ 
Printed name of research subject (if applicable :)  Representative’s relationship to  
or *research subject’s legal representative    research subject 
  
*(If, applicable) Please explain Representative’s relationship to subject and include a description of Representative’s 
authority to act on behalf of subject: 
 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
 
________________________________________________________________          _________ 
Name of [authorized] person obtaining informed consent/HIPAA authorization    Date 
  
 
X Haley Fuller BSN, DNP STUDENT/ _______________________________________ 
Signature of Principal Investigator or Sub/Co-Investigator 
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Table 1.  Demographic and Characteristics  
(N=15) 
 
 
 
Characteristic Mean (SD); n (%) 
Age 67.6 (10.7) 
Gender 
   Male 
   Female 
 
5 (33.3 %) 
10(66.7%) 
Race 
   White 
   Other 
 
15 (100.0%) 
0 (0.0%) 
Income 
   Earned 
   Social Assistance 
   Unemployed 
   Retired 
   Disabled 
 
1.93(0.258);1(6.7%) 
1.20(0.414); 12(80%) 
1.13(0.352); 13(86.7%) 
1.67(0.488); 5(33.3%) 
1.60(0.507); 6(40%) 
Smoking status 
   Smoker 
   Non-smoker 
1.80(9=0.414) 
3(20%) 
12(80%) 
NYHA class 
   I 
   II 
   II 
   IV 
    
 
1(6.7%) 
2(13.3%) 
11(73.3%) 
1(6.7%) 
AHA stage 
   A 
   B 
   C 
   D 
 
 
0(0%) 
0(0%) 
15(100%) 
0(0%) 
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Table 2: Changes Over Time in Knowledge and Self-Efficacy 
 
 Baseline 30-day 60-day F (p) 
Knowledge 68.60a 89.93b 92.84c P<0.001 
Self-efficacy 
Maintenance 
Confidence 
Management 
 
 
44.9(26.4) 
52.3(30.2) 
52.3 (30.2)a 
 
74.7(8.7) 
67.1 (17.1)b 
 
77.5(8.7) 
74.1 (17.4)b 
 
0.002 
0.002 
0.14 
(N=15) 
*Means with different letters are significantly different 
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Table 3: Outcome Variables 
Outcomes n (%); mean(SD) 
Readmission(30-day) 
   Yes 
   No 
 
3(20%) 
12(80%) 
Weight 
   Baseline 
   30-day  
   60-day 
 
176(35) 
172.2(35.7) 
172(35.2) 
 
*Wilks Lambda non-significant p= 0.057 
Edema (yes or no) 
   Baseline 
   30-day 
   60-day 
     
 
0.33(0.488) 
0.40(0.507) 
0.20(04.14) 
 
*Wilks Lamba non-significant p = 0.432 
Prevention Diuretic  
   Yes    
   No 
 
5(33.3%) 
10(66.7%) 
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Table 4: SPSS Output/ Knowledge 
Question: Does heart failure clinic face to face education with an added telephone 
intervention increase knowledge scores? 
 
 
 
  
 
 
*Descriptive stats for knowledge at each time point (below)– there was a significant difference in knowledge over 
time (F=15.6; p<.001) 
 
 
 
 
Estimates 
Measure:   MEASURE_1 
factor1 Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Baseline 68.597 5.606 56.575 80.620 
30 89.963 1.607 86.517 93.408 
60 92.839 1.675 89.247 96.431 
Pairwise Comparisons 
Measure:   MEASURE_1 
(I) 
factor1 
(J) 
factor1 
Mean 
Difference 
(I-J) 
Std. 
Error Sig.b 
95% Confidence Interval 
for Differenceb 
Lower 
Bound 
Upper 
Bound 
baseline 30 -21.365* 4.804 .001 -31.668 -11.062 
60 -24.241* 4.703 .000 -34.328 -14.155 
30 baseline 21.365* 4.804 .001 11.062 31.668 
60 -2.876* 1.068 .017 -5.166 -.586 
3 1 24.241* 4.703 .000 14.155 34.328 
2 2.876* 1.068 .017 .586 5.166 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent 
to no adjustments). 
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Table 5: SPSS Output/Maintenance 
Question: Does heart failure clinic face to face education with an added telephone intervention increase self-
efficacy maintenance? 
 
Descriptive Statistics 
 Mean 
Std. 
Deviation N 
SE PRE: A. 
MAINTENANCE 
44.8820 26.38856 15 
SE-30 DAY A. 
MAINTENANCE 
74.65953 8.710871 15 
SE-60 DAY A. 
MAINTENANCE 
77.54727 8.678839 15 
 
 
*Significant change in SE maintenance over time (F=10.7; p=.002) 
 
 
 
 
 
Pairwise Comparisons 
Measure:   MEASURE_1   
(I) 
factor1 (J) factor1 
Mean 
Difference (I-
J) 
Std. 
Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -29.778* 6.911 .001 -44.599 -14.956 
3 -32.665* 7.038 .000 -47.760 -17.570 
2 1 29.778* 6.911 .001 14.956 44.599 
3 -2.888 1.375 .054 -5.837 .062 
3 1 32.665* 7.038 .000 17.570 47.760 
2 2.888 1.375 .054 -.062 5.837 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no 
adjustments). 
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Table 6:SPSS Output/ Management 
Question: Does heart failure clinic face to face education with an added telephone intervention increase self-
efficacy management? 
 
 
 
 
No 
change in management SE over time (this was based on only 4 patients with data at all three-time points) F=4.1; 
p=.14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimates 
Measure:   MEASURE_1   
 
 
time Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 33.750 15.326 -15.025 82.525 
2 61.250 10.483 27.888 94.612 
3 61.250 10.483 27.888 94.612 
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Table 7:SPSS Output/Confidence 
Question: Does heart failure clinic face to face education with an added telephone intervention increase self-
efficacy confidence? 
 
Estimates 
Measure:   MEASURE_1   
time Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 52.264 7.803 35.528 69.000 
2 67.083 4.426 57.589 76.576 
3 74.128 4.498 64.481 83.775 
 
 
Pairwise Comparisons 
Measure:   MEASURE_1   
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -14.819* 6.878 .049 -29.570 -.067 
3 -21.864* 6.222 .003 -35.208 -8.520 
2 1 14.819* 6.878 .049 .067 29.570 
3 -7.045* 2.394 .011 -12.181 -1.910 
3 1 21.864* 6.222 .003 8.520 35.208 
2 7.045* 2.394 .011 1.910 12.181 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no adjustments). 
 
 
*Significant difference from baseline to 30-day and baseline to 60-day, but no difference in 30- to 60-day. 
Significant change in confidence over time (F=10.8; p=.002) 
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Table 8: SPSS Output/ Readmissions and Diuretic 
Question: What percent of study patients were readmitted and how many required a diuretic? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 DAY-READMISSION 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid yes 3 20.0 20.0 20.0 
no 12 80.0 80.0 100.0 
Total 15 100.0 100.0  
PREVENTION DIURETIC 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid yes 5 33.3 33.3 33.3 
no 10 66.7 66.7 100.0 
Total 15 100.0 100.0  
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Table 9: SPSS Output/ Weight 
Question: Did the study patients have significant weight changes? 
Weight 
 
*The p value is 0.06. This is only marginally statistically significant.  Since the P value is not significant there is no 
need for a post hoc analysis.  
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Table 10: SPSS Output/Edema  
Question: Did the study patients have edema? 
 
 
Edema
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Table 11: SPSS Output/Demographics  
Question: What are the demographics of this study sample?  
Gender:  
GENDER1male2female 
 Value Count Percent 
Standard Attributes Label GENDER 1= 
male 2= female 
  
Valid Values 1 M 5 33.3% 
2 F 10 66.7% 
 
Smoking status: 
 
Statistics 
SMOKING STATUS   
N Valid 15 
Missing 0 
Mean 1.80 
Std. Deviation .414 
Range 1 
Sum 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SMOKING STATUS 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid yes 3 20.0 20.0 20.0 
no 12 80.0 80.0 100.0 
Total 15 100.0 100.0  
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Table 12: SPSS Output/Income  
 
Question: What are the income statistics for this study sample? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistics 
 
EARNED 
INCOME 
SOCIAL 
ASSISTANCE UNEMPLOYED RETIRED DISABLED 
N Valid 15 15 15 15 15 
Missing 0 0 0 0 0 
Mean 1.93 1.20 1.13 1.67 1.60 
      
Std. Deviation .258 .414 .352 .488 .507 
Range 1 1 1 1 1 
Sum 29 18 17 25 24 
SOCIAL ASSISTANCE 
 Frequency Percent Valid Percent Cumulative Percent 
Valid yes 12 80.0 80.0 80.0 
no 3 20.0 20.0 100.0 
Total 15 100.0 100.0  
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Table 12: SPSS Output/Income continued… 
 
 
UNEMPLOYED 
 Frequency Percent Valid Percent Cumulative Percent 
Valid yes 13 86.7 86.7 86.7 
no 2 13.3 13.3 100.0 
Total 15 100.0 100.0  
 
 
RETIRED 
 Frequency Percent Valid Percent Cumulative Percent 
Valid yes 5 33.3 33.3 33.3 
no 10 66.7 66.7 100.0 
Total 15 100.0 100.0  
 
DISABLED 
 Frequency Percent Valid Percent Cumulative Percent 
     
Valid yes 6 40.0 40.0 40.0 
no 9 60.0 60.0 100.0 
Total 15 100.0 100.0  
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Figure 1: Heart Failure Effective Transition Care Model 
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Figure 2: Plan, Do, Study, Act Cycle 
(Melnyk et al., 2015, pp. 83)  
 
 
 
 
Do
ActStudy
Plan
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Figure 3: Stetler Model of Evidence Based Practice Implementation 
 (Melnyk et al., 2015, pp. 211) 
-Evaluate use 
in organization
-Cost 
analysis(monet
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V: 
Evaluation
Type: 
1. Cognitive use: validate 
current HF clinic practice 
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continued research).
2.  Direct instrumental use: 
change HF program to 
incorporate self-efficacy 
and knowledge validated 
tools in practice. 
Methods:
Informal
Per results
Level: Department (key 
stakeholders)
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IV:
Translation/
Application
-Pre/Post test to assess 
self efficacy and 
knowledge
-Measure 30-day 
readmission rates
-Feasibility to implement 
this intervention into 
current practice at Baptist 
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of follow up with an 
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-Method of application: 
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III:
Comparative 
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efficacy and 
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- Provider and 
patient 
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II:
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care.
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Figure 4: NYHA Functional Class Distribution of Study Patients 
 
 
 
 
 
 
 110 
 
Figure 5: Costs and Implications 
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Figure 6: Quantifying the Value 
 
 
